Spirochaetal infections, other/unspecified, including avohilmo

AB1_SPIROCHE_OTHER_WIDE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Primary healthcare outpatient: ICD-10 — A69 Hospital discharge: ICD-10 — A69 Hospital discharge: ICD-9 — 10[4] Hospital discharge: ICD-8 — 10[4] Hospital discharge: excluded ICD-9 — 1040A Hospital discharge: excluded ICD-8 — 1040 Cause of death: ICD-10 — A69 Cause of death: ICD-9 — 10[4] Cause of death: ICD-8 — 10[4] Cause of death: excluded ICD-9 — 1040A Cause of death: excluded ICD-8 — 1040 3 out of 7 registries used, show all original rules.	17986
4. Check minimum number of events None	17986
5. Include endpoints None	17986
6. Filter based on genotype QC (FinnGen only)	16467

Control definitions (FinnGen only)

Control exclude: AB1_OTHER_SPIROCHAETAL

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF13

NAME	AB1_SPIROCHE_OTHER_WIDE
CONTROL_EXCLUDE	AB1_OTHER_SPIROCHAETAL
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD	A69
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	A69
HD_ICD_9	10[4]
HD_ICD_8	10[4]
HD_ICD_10_EXCL
HD_ICD_9_EXCL	1040A
HD_ICD_8_EXCL	1040
COD_MAINONLY
COD_ICD_10	A69
COD_ICD_9	10[4]
COD_ICD_8	10[4]
COD_ICD_10_EXCL
COD_ICD_9_EXCL	1040A
COD_ICD_8_EXCL	1040
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Spirochaetal infections, other/unspecified, including avohilmo based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	16467	10355	6112
Unadjusted period prevalence (%)	3.35	3.68	2.80
Median age at first event (years)	63.37	62.38	65.05

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
17065: Matched controls
170649

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

A69.2

ICD-10 Finland

Lyme disease

351086.2

307.7

16679

J01CA04

ATC

amoxicillin; systemic

4.0

307.7

15532

122405

W57

ICD-10 Finland

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

4.4

307.7

1081

2558

S12

ICPC

Insect bite/sting

7.5

307.7

4397

7512

M01.2*A69.2

ICD-10 Finland

Arthritis in Lyme disease

116.8

272.8

139

S29

ICPC

Skin symptom/complaint other

1.7

179.1

3814

24180

G63.0*A69.2

ICD-10 Finland

Polyneuropathy (in) Lyme disease

355.0

175.7

177

S73

ICPC

Pediculosis/skin infestation other

11.8

172.6

176

151

S72

ICPC

Scabies/other acariasis

4.9

161.9

362

753

J01AA02

ATC

doxycycline; systemic

1.6

148.2

13154

114955

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.6

132.4

3819

25902

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

124.8

3694

25158

G01*A69.2

ICD-10 Finland

Meningitis (in) Lyme disease

1217.7

124.1

121

TAB00

NOMESCO Finland

Lumbar puncture

2.3

108.9

834

3671

L82

ICD-10 Finland

Seborrhoeic keratosis

1.5

95.2

3221

22424

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

94.4

2278

14652

S13

ICPC

Animal/human bite

2.4

89.6

667

2896

A98

ICPC

Health maint/preventive medicine

2.9

87.8

16725

161154

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

84.8

2936

20482

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.8

84.5

1340

7665

M25.5

ICD-10 Finland

Pain in joint

1.4

84.3

5503

43280

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

2.3

84.0

673

3015

SPAT1262

SPAT

Handing over of treatment supplies

0.5

83.0

1049

18630

1048A

ICD-9 Finland

Other spirochaetal infection, Other specified spirochaetal infections[MORBUS LYME]

+∞

81.3

103

Kela drug reimbursment

Diabetes, insulin-treated

0.6

80.7

2061

30538

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

79.3

4896

38052

SPAT1152

SPAT

Removal of foreign body from under the skin

2.7

78.7

441

1675

Z2221

NOMESCO Finland

Medical doctor

1.4

74.7

4143

31542

S08

ICPC

Skin colour change

1.9

72.1

915

4871

S06

ICPC

Rash localized

1.9

71.0

931

5009

B88.0

ICD-10 Finland

Other acariasis

6.3

70.9

118

187

L57.0

ICD-10 Finland

Actinic keratosis

1.6

68.3

1563

9872

215

Kela drug reimbursment

Diabetes, non-insulin-treated

0.7

64.4

2045

29144

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

63.7

7956

68150

A10BA02

ATC

metformin; oral

0.7

60.0

2398

32775

A69.10

ICD-10 Finland

Acute necrotizing ulcerative gingivitis (ANUG)

+∞

59.4

N73

ICPC

Neurological infection other

18.4

57.7

205

Kela drug reimbursment

Chronic hypertension

0.7

55.7

1931

27167

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

0.7

54.7

1918

26936

C03CA01

ATC

furosemide; systemic

0.7

54.2

2245

30578

SPAT1324

SPAT

Screening procedure

0.6

53.4

1306

19768

A69.9

ICD-10 Finland

Spirochaetal infection, unspecified

+∞

50.0

M04AB01

ATC

probenecid; oral

10.6

49.6

G51.0

ICD-10 Finland

Bell palsy

2.2

49.6

422

1937

T90

ICPC

Diabetes non-insulin dependent

0.7

49.2

2124

28792

R83

ICPC

Respiratory infection other

1.3

48.9

3838

30526

D22

ICD-10 Finland

Melanocytic naevi

1.7

48.6

862

5075

M01AH05

ATC

etoricoxib; oral

1.3

47.9

10126

91248

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.3

47.7

3536

27873

D19

ICPC

Teeth/gum symptom/complaint

1.3

46.8

4817

39723

WX725

NOMESCO Finland

Noninvasive ventilation

0.4

46.7

203

5413

L548, A692,

ICD-10 Finland

+∞

45.8

Z02.4

ICD-10 Finland

Examination for driving licence

1.3

45.6

3956

31862

M79.6

ICD-10 Finland

Pain in limb

1.3

44.9

6997

60643

S21

ICPC

Skin texture symptom/complaint

1.4

44.8

2318

17243

A10AE04

ATC

insulin glargine; parenteral

0.5

43.6

495

9186

Z01.7

ICD-10 Finland

Laboratory examination

1.4

43.4

2550

19362

Z71.8

ICD-10 Finland

Other specified counselling

1.3

43.4

5266

44244

WX720

NOMESCO Finland

Own respiration

0.4

42.0

165

4613

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

0.7

42.0

2244

29479

WW200, ,

SPAT

1.3

40.9

4639

38586

H02

ICPC

Hearing complaint

1.4

40.5

2102

15624

R06AX27

ATC

desloratadine; oral

1.3

38.9

4329

35880

J01FA10

ATC

azithromycin; systemic

1.2

38.7

8955

80559

D01AE16

ATC

amorolfine; topical

1.4

36.0

1610

11648

ZXD10

NOMESCO Finland

Scheduled procedure

1.2

36.0

5381

46067

H02AB07

ATC

prednisone; oral

1.4

35.3

1845

13710

WX704

NOMESCO Finland

Intubation

0.6

35.2

489

8567

A23

ICPC

Risk factor NOS

1.4

34.9

1400

9931

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

2.0

34.8

407

2105

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

0.7

34.5

1264

17771

A97

ICPC

No disease

1.3

34.5

2953

23613

A10AC01

ATC

insulin (human); parenteral

0.5

34.3

298

6043

R01AD09

ATC

mometasone; nasal

1.2

34.1

6937

61252

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

1.6

33.9

722

4458

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

0.6

33.0

649

10402

R20.2

ICD-10 Finland

Paraesthesia of skin

1.5

33.0

1053

7137

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

0.5

32.8

339

6494

GD1AA, ,

SPAT

1.3

32.5

2361

18443

A10AB05

ATC

insulin aspart; parenteral

0.5

32.4

380

6996

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.3

32.3

3296

26929

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

0.7

32.1

934

13736

SPAT1254

SPAT

Administration of medicine

0.7

32.1

992

14414

I50.9

ICD-10 Finland

Heart failure, unspecified

0.6

31.7

699

10910

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.6

31.4

808

5223

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.4

30.8

1858

14112

H10

ICD-10 Finland

Conjunctivitis

1.5

30.7

1023

6992

UJF30

NOMESCO Finland

Ileoscopy through colon

1.4

30.7

1536

11317

H93.1

ICD-10 Finland

Tinnitus

1.5

30.6

1018

6958

J01DB01

ATC

cefalexin; oral

1.2

30.2

13296

126022

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

0.5

30.2

257

5246

SPAT1249

SPAT

Treatment-related counselling outside office

0.8

29.9

4226

49389

S82

ICPC

Naevus/mole

1.3

29.8

2056

15922

L53.9

ICD-10 Finland

Erythematous condition, unspecified

2.4

29.7

201

839

Z11.3

ICD-10 Finland

Special screening examination for infections with a predominantly sexual mode of transmission

1.6

29.6

694

4388

D01BA02

ATC

terbinafine; oral

1.3

29.6

3629

30253

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.2

29.6

4077

34435

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.4

29.2

1516

11235

R01AD08

ATC

fluticasone; nasal

1.2

29.0

4162

35288

EB1AA, ,

SPAT

1.5

29.0

914

6178

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

0.7

29.0

1245

17054

TPH07

NOMESCO Finland

Cathetrisation of artery

0.7

28.8

777

11617

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

0.6

28.6

716

10874

V18

ICD-10 Finland

Pedal cyclist injured in noncollision transport accident

3.1

28.6

117

376

SPAT1263

SPAT

Sampling

0.8

28.5

4599

53093

DFF00

NOMESCO Finland

Pure tone audiometry

1.4

28.4

1414

10404

C01CA24

ATC

epinephrine; parenteral

1.5

28.4

847

5656

SPAT1222

SPAT

Counselling/guidance promoting independent living

0.7

28.2

1047

14716

A28

ICPC

Limited function/disability NOS

0.7

27.9

1285

17412

D06BB10

ATC

imiquimod; topical

1.6

27.8

705

4543

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.2

27.7

3663

30756

Z51.5

ICD-10 Finland

Palliative care

0.6

27.7

476

7892

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.4

27.4

1250

9061

R05

ICD-10 Finland

Cough

1.3

27.4

3155

26082

A69

ICD-10 Finland

Other spirochaetal infections

+∞

27.1

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

0.6

26.9

473

7798

I50.0

ICD-10 Finland

Congestive heart failure

0.5

26.7

248

4918

J05AB11

ATC

valaciclovir; oral

1.3

26.3

2075

16358

130

Kela drug reimbursment

Malignant tumour

0.6

26.2

513

8240

X58

ICD-10 Finland

Exposure to other specified factors

1.3

26.1

2066

16291

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.2

26.1

6336

56426

L17

ICPC

Foot/toe symptom/complaint

1.2

25.9

4581

39592

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

0.4

25.9

170

3814

R4110

NOMESCO Finland

Physiotherapy

1.2

25.8

3950

33651

W86

ICD-10 Finland

Exposure to other specified electric current

3.3

25.7

292

HA1RA, ,

SPAT

1.6

25.7

671

4353

OAB50, ,

SPAT

0.6

25.6

539

8510

R74

ICPC

Upper respiratory infection acute

1.2

25.2

4811

41863

M79.1

ICD-10 Finland

Myalgia

1.3

25.0

2124

16896

S18

ICPC

Laceration/cut

1.2

25.0

7097

63992

R51.80

ICD-10 Finland

Headache

1.3

24.9

2172

17335

Z20.7

ICD-10 Finland

Contact with and exposure to pediculosis, acariasis and other infestations

4.7

24.9

122

R52.9

ICD-10 Finland

Pain, unspecified

1.4

24.9

1481

11208

M01.2

ICD-10 Finland

Arthritis in Lyme disease

38.9

24.8

SPAT1097

SPAT

Recording of ECG

0.7

24.7

1105

15062

B35.1

ICD-10 Finland

Tinea unguium

1.5

24.7

940

6594

J31.0

ICD-10 Finland

Chronic rhinitis

1.4

24.6

1195

8754

H04.10

ICD-10 Finland

Dry eye syndrome

1.3

24.6

1737

13479

B02

ICD-10 Finland

Zoster [herpes zoster]

1.6

24.5

604

3866

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.2

24.3

4501

39031

F29

ICPC

Eye symptom/complaint other

1.3

24.0

1520

11610

A10BB12

ATC

glimepiride; oral

0.5

23.9

250

4771

N02AA05

ATC

oxycodone; systemic

0.7

23.8

1474

19123

G04CA01

ATC

alfuzosin; oral

1.4

23.8

1349

10132

A06AD11

ATC

lactulose; oral

0.7

23.7

962

13336

S01GX01

ATC

cromoglicic acid; ophthalmic

1.2

23.7

2827

23418

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.4

23.7

1373

10344

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

0.6

23.6

393

6571

N05AX08

ATC

risperidone; systemic

0.6

23.3

422

6911

M01AE02

ATC

naproxen; oral, rectal

1.2

23.3

8510

78190

PH2AE, ,

SPAT

1.9

23.3

309

1671

L08

ICPC

Shoulder symptom/complaint

1.2

23.2

3386

28656

SDA03

NOMESCO Finland

Periodontal treatment

1.2

23.1

6207

55579

A10BH01

ATC

sitagliptin; oral

0.7

23.0

610

9162

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.2

23.0

7342

66695

H81

ICPC

Excessive ear wax

1.3

22.9

2315

18803

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.4

22.7

1283

9629

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.2

22.5

3367

28555

UDC00

NOMESCO Finland

Ear microscopy

0.6

22.5

438

7044

M03BX02

ATC

tizanidine; oral

1.2

22.4

9686

90089

J20

ICD-10 Finland

Acute bronchitis

1.3

21.9

1445

11098

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

0.6

21.9

542

8258

Z71.9

ICD-10 Finland

Counselling, unspecified

1.4

21.5

1094

8073

L30

ICD-10 Finland

Other dermatitis

1.8

21.2

326

1844

F38

ICPC

Eye, Other laboratory test NEC

2.0

21.1

243

1254

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

0.5

21.0

175

3594

G04.9

ICD-10 Finland

Encephalitis, myelitis and encephalomyelitis, unspecified

3.8

21.0

162

TPH04

NOMESCO Finland

Cathetrisation of vein

0.8

20.9

2112

25786

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.3

20.9

1322

10087

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

20.9

2273

18610

N05AA02

ATC

levomepromazine; systemic

0.4

20.9

140

3111

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.3

20.5

1897

15232

K08.80

ICD-10 Finland

Toothache NOS

1.3

20.4

1244

9437

R51

ICD-10 Finland

Headache

1.5

20.3

742

5163

A10AE05

ATC

insulin detemir; parenteral

0.5

20.3

237

4371

SPAT1301

SPAT

No procedures

0.8

20.3

3166

36944

H53.1

ICD-10 Finland

Subjective visual disturbances

1.4

20.1

970

7092

TQW99

NOMESCO Finland

Other minor procedure on skin

1.5

20.1

612

4107

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.4

20.1

780

5492

Z01.2

ICD-10 Finland

Dental examination

1.2

19.9

7117

64960

G63.0

ICD-10 Finland

Polyneuropathy in infectious and parasitic diseases classified elsewhere

28.9

19.6

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.6

19.4

448

2825

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.3

19.4

1547

12186

H01.0

ICD-10 Finland

Blepharitis

1.4

19.3

930

6802

N95.2

ICD-10 Finland

Postmenopausal atrophic vaginitis

1.3

19.2

1200

9136

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.2

19.1

6936

63311

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

0.6

19.0

333

5492

R01AD58

ATC

fluticasone, combinations; nasal

1.2

18.9

3565

30836

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

1.5

18.7

689

4804

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.4

18.7

799

5724

A44

ICPC

General and Unspecified, Preventive immunization/medic

1.3

18.6

1133

8597

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.3

18.5

1326

10296

L01

ICPC

Neck symptom/complaint

1.2

18.5

2301

19105

EB1SA, ,

SPAT

1.5

18.4

673

4685

I78.1

ICD-10 Finland

Naevus, non-neoplastic

1.8

18.3

289

1651

R07.4

ICD-10 Finland

Chest pain, unspecified

1.2

18.1

3931

34406

SPAT1304

SPAT

Counselling and guidance related to ageing

0.6

18.1

334

5439

M54

ICD-10 Finland

Dorsalgia

1.3

18.0

1679

13482

L15

ICPC

Knee symptom/complaint

1.2

18.0

3687

32104

M01AE01

ATC

ibuprofen; systemic, rectal

1.2

18.0

14669

142204

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.2

17.8

3284

28330

H92.0

ICD-10 Finland

Otalgia

1.4

17.8

836

6088

EBA15

NOMESCO Finland

Extraction of multiple teeth

0.5

17.8

164

3253

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.5

17.7

502

3319

SPAT1100

SPAT

Long-term monitoring of blood pressure

0.6

17.7

322

5265

F02.89*A69.2

ICD-10 Finland

Dementia in Lyme disease

+∞

17.7

L03

ICPC

Low back symptom/complaint

1.2

17.6

4245

37469

F20.9

ICD-10 Finland

Schizophrenia, unspecified

0.3

17.6

1459

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

0.6

17.4

386

6023

NG2AA

NOMESCO Finland

Patella X-ray examination

1.6

17.2

370

2297

N05AH03

ATC

olanzapine; systemic

0.6

17.1

361

5697

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

0.8

17.0

1387

17406

L08

ICD-10 Finland

Other local infections of skin and subcutaneous tissue

1.8

17.0

231

1261

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

0.6

16.9

382

5941

Z04.3

ICD-10 Finland

Examination and observation following other accident

1.8

16.9

248

1387

M67.4

ICD-10 Finland

Ganglion

1.4

16.8

908

6765

XX3DW

NOMESCO Finland

Time consuming IT work

0.7

16.7

833

11187

L13

ICPC

Hip symptom/complaint

1.2

16.7

2738

23353

SPAT1193

SPAT

Pap smear

0.7

16.6

608

8591

T78.4

ICD-10 Finland

Allergy, unspecified

1.5

16.6

580

4005

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

0.5

16.6

175

3322

A04AA02

ATC

granisetron; systemic, transdermal

0.7

16.5

422

6390

TK800

NOMESCO Finland

Hemodialysis

0.3

16.3

1491

J18.9

ICD-10 Finland

Pneumonia, unspecified

0.8

16.2

2317

27358

-31

ICPC

Medical examin/health eval partial

0.6

16.2

384

5905

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

0.6

16.2

354

5541

K03.64

ICD-10 Finland

Dental calculus supragingival

1.2

16.2

4696

42008

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.2

16.1

5259

47454

A10BB01

ATC

glibenclamide; oral

0.4

16.1

1780

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.2

15.9

3644

31981

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

1.4

15.8

772

5656

R00.2

ICD-10 Finland

Palpitations

1.3

15.8

1070

8240

R42

ICD-10 Finland

Dizziness and giddiness

1.2

15.8

3091

26774

T63.4

ICD-10 Finland

Toxic effect: Venom of other arthropods

2.1

15.7

153

746

S61.0

ICD-10 Finland

Open wound of finger(s) without damage to nail

1.3

15.7

1165

9087

A69.0

ICD-10 Finland

Necrotizing ulcerative stomatitis

+∞

15.6

L54.8

ICD-10 Finland

Erythema in other diseases classified elsewhere

12.9

15.6

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.3

15.5

1526

12326

A10BK03

ATC

empagliflozin; oral

0.7

15.5

809

10790

G01

ICD-10 Finland

Meningitis in bacterial diseases classified elsewhere

160.1

15.5

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.2

15.4

4267

38002

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.2

15.4

2705

23195

L53.8

ICD-10 Finland

Other specified erythematous conditions

3.2

15.4

194

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

0.8

15.4

1433

17707

SPAT1148

SPAT

Treatment of chronic ulcer or burn

0.8

15.4

978

12677

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

1.4

15.3

568

3967

CS494

NOMESCO Finland

Other visual field testing

1.6

15.3

318

1958

N17.9

ICD-10 Finland

Acute renal failure, unspecified

0.5

15.3

169

3162

SPAT1229

SPAT

Assessment of need for aid

0.7

15.2

444

6546

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

0.6

15.2

233

3974

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

0.6

15.2

336

5245

ZX080

NOMESCO Finland

Image guided radiotherapy

0.4

15.1

1611

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

0.5

15.1

155

2966

M75

ICD-10 Finland

Shoulder lesions

1.4

15.1

570

3996

OAB95, ,

SPAT

1.3

15.0

994

7633

R06AX22

ATC

ebastine; oral

1.2

15.0

2324

19698

SPAT1360

SPAT

Extensive global examination

1.4

14.9

813

6067

WX780

NOMESCO Finland

Remote monitoring CPAP

0.6

14.8

256

4237

G44.2

ICD-10 Finland

Tension-type headache

1.2

14.8

1838

15233

WX002

NOMESCO Finland

Sedation and analgesia

1.2

14.8

2464

21022

HMAK, ,

NOMESCO Finland

0.8

14.8

922

11985

R99

ICD-10 Finland

Other ill-defined and unspecified causes of mortality

0.3

14.7

1439

H48.1*A69.2

ICD-10 Finland

Retrobulbar neuritis in Lyme disease

+∞

14.6

F45.8

ICD-10 Finland

Other somatoform disorders

1.3

14.5

836

6288

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

1.7

14.5

238

1377

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

0.3

14.5

1322

NH3AA, ,

SPAT

1.4

14.5

720

5293

H02AB02

ATC

dexamethasone; systemic

0.8

14.5

979

12591

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

1.3

14.4

1272

10141

N18.8

ICD-10 Finland

Other chronic renal failure

0.3

14.4

1500

NG1BG, ,

SPAT

1.5

14.4

500

3451

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

1.4

14.4

576

4082

Z00.6

ICD-10 Finland

Examination for normal comparison and control in clinical research programme

1.9

14.3

173

911

OAA67, ,

SPAT

1.2

14.3

2230

18906

HARJA, ,

NOMESCO Finland

3.2

14.3

172

D01

ICPC

Abdominal pain/cramps general

1.2

14.3

1645

13524

R21

ICPC

Throat symptom/complaint

1.2

14.3

2823

24452

J01

ICD-10 Finland

Acute sinusitis

1.4

14.2

722

5326

M01AB05

ATC

diclofenac; systemic, rectal

1.1

14.2

10054

95228

WX723

NOMESCO Finland

CPAP therapy

0.6

14.1

253

4143

F29

ICD-10 Finland

Unspecified nonorganic psychosis

0.5

14.0

142

2727

N30

ICD-10 Finland

Cystitis

1.3

14.0

1062

8305

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

0.3

14.0

1433

SPAT1245

SPAT

Provision of support and information to patient’s family members

0.5

13.9

134

2612

WX110, ,

SPAT

1.4

13.9

708

5229

A02BC04

ATC

rabeprazole; oral

1.3

13.8

1144

9047

N17

ICPC

Vertigo/dizziness

1.2

13.8

1647

13588

K02.0

ICD-10 Finland

Caries limited to enamel

1.2

13.8

2681

23179

A10AA02, ,

ATC

0.5

13.7

2105

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

0.7

13.7

378

5631

J01MA01

ATC

ofloxacin; systemic

1.3

13.6

907

6969

H60

ICD-10 Finland

Otitis externa

1.4

13.6

662

4850

G04CB01

ATC

finasteride; oral

1.3

13.6

976

7577

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

0.6

13.6

190

3317

C03DA01

ATC

spironolactone; oral

0.8

13.5

924

11864

SPAT1377

SPAT

Polysomnography

0.5

13.5

147

2757

A10BJ06

ATC

semaglutide; parenteral

0.7

13.4

343

5191

R35

ICD-10 Finland

Polyuria

1.3

13.4

807

6110

SPAT1395

SPAT

Health check-up of persons outside student and working life

0.4

13.4

1891

L12

ICPC

Hand/finger symptom/complaint

1.2

13.4

2384

20453

I50.1

ICD-10 Finland

Left ventricular failure

0.6

13.3

184

3223

R06AE07

ATC

cetirizine; oral

1.1

13.3

6403

59106

E66.01

ICD-10 Finland

Obesity due to excess calories

0.8

13.3

783

10259

A10BH05

ATC

linagliptin; oral

0.6

13.2

252

4067

B01AB10

ATC

tinzaparin; parenteral

0.8

13.0

950

12101

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

0.4

13.0

1814

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

0.6

13.0

229

3766

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

0.6

13.0

317

4840

L90.4

ICD-10 Finland

Acrodermatitis chronica atrophicans

10.9

13.0

Z00.0

ICD-10 Finland

General medical examination

1.2

13.0

2538

21945

R01BA52

ATC

pseudoephedrine, combinations; oral

1.1

13.0

4207

37820

A10AB01

ATC

insulin (human); parenteral

0.5

13.0

126

2450

HA1AE, ,

SPAT

1.5

12.9

418

2846

K30

ICD-10 Finland

Functional dyspepsia

1.2

12.9

1521

12532

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

0.8

12.9

1186

14690

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

1.2

12.9

1900

16012

R03BA02

ATC

budesonide; inhalant

1.2

12.9

2339

20093

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.5

12.9

435

2988

C09AA05

ATC

ramipril; oral

0.8

12.8

2294

26599

XF400

NOMESCO Finland

ECG with 12 standard connections

1.2

12.8

1777

14888

M15

ICD-10 Finland

Polyarthrosis

1.4

12.8

632

4644

SPAT1256

SPAT

Intramuscular and subcutaneous injection

0.9

12.8

4742

52067

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

0.8

12.8

939

11947

H25.0

ICD-10 Finland

Senile incipient cataract

1.3

12.7

777

5898

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

0.4

12.6

1465

I10

ICD-10 Finland

Essential (primary) hypertension

0.9

12.6

7830

83316

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.4

12.6

696

5207

S04

ICPC

Lump/swelling localized

1.2

12.5

1444

11867

A69.8

ICD-10 Finland

Other specified spirochaetal infections

+∞

12.5

J05AB01

ATC

aciclovir; systemic

1.2

12.5

2927

25677

P72

ICPC

Schizophrenia

0.3

12.5

1311

H61.2

ICD-10 Finland

Impacted cerumen

1.3

12.4

843

6494

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

1.8

12.4

177

984

N05AD01

ATC

haloperidol; systemic

0.5

12.4

2014

ZX070

NOMESCO Finland

Intensity modified radiotherapy

0.3

12.3

1227

A06AC51

ATC

ispaghula, combinations; oral

1.4

12.3

576

4197

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.1

12.3

7696

72068

J02AC02

ATC

itraconazole; systemic

1.2

12.3

2332

20108

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.2

12.2

1332

10880

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.3

12.2

1194

9636

R07.3

ICD-10 Finland

Other chest pain

1.2

12.1

1319

10771

A02BC05

ATC

esomeprazole; systemic

1.1

12.1

5809

53514

N02AJ06

ATC

codeine and paracetamol; systemic

1.1

12.1

6326

58585

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.2

12.1

1693

14193

U07.2

ICD-10 Finland

COVID-19, virus not identified

1.2

12.1

2495

21663

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.2

12.0

1392

11444

R22

ICD-10 Finland

Localized swelling, mass and lump of skin and subcutaneous tissue

1.5

12.0

310

2013

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.3

12.0

978

7719

H29

ICPC

Ear symptom/complaint other

1.2

12.0

1595

13306

EBA00

NOMESCO Finland

Extraction of tooth

0.9

12.0

4242

46764

N05AF03

ATC

chlorprothixene; systemic

0.5

11.9

1971

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

1.5

11.8

413

2857

A10AE06

ATC

insulin degludec; parenteral

0.6

11.8

173

2980

A06AC01

ATC

ispaghula (psylla seeds); oral

1.2

11.8

3569

31896

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

1.6

11.8

256

1598

XF402

NOMESCO Finland

ECG with work load test

1.2

11.8

1240

10091

H02AB04

ATC

methylprednisolone; systemic

1.2

11.8

1826

15460

M23

ICD-10 Finland

Internal derangement of knee

1.5

11.7

305

1986

J37.0

ICD-10 Finland

Chronic laryngitis

1.5

11.7

397

2731

A49.9

ICD-10 Finland

Bacterial infection, unspecified

0.8

11.7

837

10688

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

0.6

11.7

172

2959

M77.4

ICD-10 Finland

Metatarsalgia

1.3

11.7

787

6059

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

0.2

11.7

499

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

0.8

11.7

1062

13174

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.2

11.7

2973

26235

J01MA06

ATC

norfloxacin; oral

1.2

11.6

1567

13086

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

0.5

11.6

1818

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

0.5

11.6

113

2192

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

0.5

11.6

109

2139

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

1.4

11.6

445

3133

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.2

11.6

1273

10411

MAX99

NOMESCO Finland

Assistance to normal delivery

1.3

11.5

672

5067

A10BD07

ATC

metformin and sitagliptin; systemic

0.6

11.5

220

3547

E11

ICD-10 Finland

Type 2 diabetes mellitus

0.8

11.5

1407

16910

NE1AA, ,

SPAT

1.6

11.5

230

1407

Z24.1

ICD-10 Finland

Need for immunization against arthropod-borne viral encephalitis

2.4

11.5

318

SAD02

NOMESCO Finland

Assessment of need for oral health care, extensive

0.6

11.5

214

3468

A84.8

ICD-10 Finland

Other tick-borne viral encephalitis

5.7

11.5

H22.0*A69.2

ICD-10 Finland

Iridocyclitis in Lyme disease

120.1

11.4

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.2

11.4

1465

12179

R01AD12

ATC

fluticasone furoate; nasal

1.1

11.3

4401

39976

XF640, ,

NOMESCO Finland

1.6

11.3

274

1755

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

0.9

11.3

2356

27001

SPAT1139

SPAT

Nutrition survey

0.6

11.3

141

2535

M01AX05

ATC

glucosamine; oral

1.2

11.3

2346

20375

2500A

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE,TYYPPI II]

0.2

11.2

778

SPAT1079

SPAT

Echocardiography

0.2

11.2

825

XQ855

NOMESCO Finland

Skin temperature measurement

2.8

11.2

199

A12BA01

ATC

potassium chloride; oral

0.5

11.2

131

2399

C10AA01

ATC

simvastatin; oral

0.9

11.1

4433

48562

R03AK07

ATC

formoterol and budesonide; inhalant

1.2

11.1

2882

25453

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.3

11.1

1064

8564

OAB43, ,

SPAT

1.1

11.1

4049

36622

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.3

11.1

906

7154

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.1

11.1

6197

57532

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.1

11.1

3586

32180

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.3

11.0

1115

9031

J45

ICD-10 Finland

Asthma

1.2

11.0

1344

11109

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

0.4

11.0

1604

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

0.6

11.0

267

4078

L57

ICD-10 Finland

Skin changes due to chronic exposure to nonionizing radiation

2.6

11.0

235

LX2A3, ,

SPAT

0.5

10.9

132

2398

T36

ICD-10 Finland

Poisoning by systemic antibiotics

0.6

10.9

221

3512

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.2

10.9

1410

11727

H02AB06

ATC

prednisolone; systemic

1.1

10.8

6801

63530

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.3

10.8

854

6718

HA1RA

NOMESCO Finland

Combined assessment of mammary gland (mammography and ultrasound)

1.5

10.8

330

2226

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

1.3

10.7

754

5840

N05AC02

ATC

thioridazine; oral

0.4

10.7

1305

N05AH02

ATC

clozapine; systemic

0.4

10.7

1202

I25.1

ICD-10 Finland

Atherosclerotic heart disease

0.8

10.7

1736

20318

H91.1

ICD-10 Finland

Presbycusis

1.3

10.6

641

4859

L29

ICPC

Musculoskeletal sympt/complt other

1.2

10.6

1145

9342

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

0.6

10.6

216

3428

3050A

ICD-9 Finland

Nondependent abuse of drugs, Alcohol abuse

0.2

10.6

447

S59

ICPC

Skin, Other therap proced/minor surg NEC

1.6

10.6

257

1649

DE2BG

NOMESCO Finland

Acoustic channel MRI examination with high intensity magnet

1.8

10.6

141

770

A11

ICPC

Chest pain NOS

1.2

10.6

1074

8707

QBE99, ,

SPAT

2.0

10.5

114

581

C09AA02

ATC

enalapril; systemic

0.8

10.5

1629

19153

M19

ICD-10 Finland

Other arthrosis

1.5

10.5

269

1746

R03BC03

ATC

nedocromil; inhalant

1.3

10.5

815

6395

A41.9

ICD-10 Finland

Sepsis, unspecified

0.6

10.5

146

2548

UGC12

NOMESCO Finland

Flexible bronchoscopy

0.7

10.5

493

6680

ZY010, ,

SPAT

1.7

10.5

180

1058

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.2

10.5

1296

10730

D23

ICD-10 Finland

Other benign neoplasms of skin

1.5

10.5

280

1836

SPAT1279

SPAT

Preparation of immediate hospitalisation

0.2

10.5

464

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.2

10.4

1612

13639

OAB47, ,

SPAT

0.7

10.4

319

4649

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

1.4

10.4

377

2628

K03.66

ICD-10 Finland

Tooth plaque

1.3

10.3

966

7757

XX9LA

NOMESCO Finland

Complementary kinetic X-ray examination without contrast

0.2

10.3

482

-1, ,

NOMESCO Finland

0.9

10.3

3699

40818

N05BA06

ATC

lorazepam; systemic, sublingual

0.7

10.2

279

4159

D07AD01

ATC

clobetasol; topical

1.2

10.2

2250

19625

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

0.6

10.1

184

2997

R52.2

ICD-10 Finland

Other chronic pain

1.4

10.1

446

3222

TUPEI, ,

NOMESCO Finland

1.4

10.1

412

2936

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.1

10.1

6702

62719

B01AF01

ATC

rivaroxaban; oral

1.2

10.1

1545

13064

B35.3

ICD-10 Finland

Tinea pedis

1.3

10.0

558

4183

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

0.3

10.0

864

SPAT1131

SPAT

Colonoscopy

0.6

10.0

144

2487

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

0.4

10.0

1046

I83.0

ICD-10 Finland

Varicose veins of lower extremities with ulcer

0.5

10.0

1487

Z37.0

ICD-10 Finland

Single live birth

1.3

9.9

731

5699

XX9CW

NOMESCO Finland

Submitting image material and/or investigation material to patient

2.0

9.9

105

532

SFB40

NOMESCO Finland

Filling of four surfaces reproduced outside mouth

2.1

9.9

418

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.4

9.8

456

3321

J01AA04

ATC

lymecycline; systemic

1.2

9.8

1595

13556

R53

ICD-10 Finland

Malaise and fatigue

1.1

9.8

3268

29357

NG1AA, ,

SPAT

1.2

9.8

1040

8475

QAE99, ,

SPAT

1.9

9.7

123

661

K59.0

ICD-10 Finland

Constipation

1.3

9.7

636

4879

ZXH09, ,

SPAT

1.5

9.7

266

1754

J02AC01

ATC

fluconazole; systemic

1.1

9.7

5643

52392

J96.1

ICD-10 Finland

Chronic respiratory failure

0.4

9.7

1263

R23

ICD-10 Finland

Other skin changes

1.8

9.7

148

843

H36.01

ICD-10 Finland

Diabetic maculopathy

0.3

9.7

816

A10AB04

ATC

insulin lispro; parenteral

0.6

9.7

133

2324

Z3226

NOMESCO Finland

Physiotherapist

1.2

9.6

2222

19438

N04AA02

ATC

biperiden; systemic

0.4

9.6

1314

K58

ICD-10 Finland

Irritable bowel syndrome

1.5

9.6

309

2107

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

0.7

9.6

479

6428

L19

ICPC

Muscle symptom/complaint NOS

1.4

9.6

344

2395

QX3HE, ,

SPAT

1.5

9.6

283

1896

WX402

NOMESCO Finland

General anaesthesia

0.9

9.6

2470

27897

K05.31

ICD-10 Finland

Periodontitis pronounced

0.8

9.5

980

11996

XX9AW

NOMESCO Finland

Production of copy from X-ray picture

1.4

9.5

406

2916

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

0.4

9.5

1109

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

1.4

9.5

371

2624

AN1

Coronary angiography

0.8

9.5

723

9159

LC2DE

NOMESCO Finland

Demanding ultrsound examination of uterus, parametrium and lower part of abdomen with speciel methods

1.4

9.5

506

3770

NJ3NA

NOMESCO Finland

Measurement of difference in extremity lengty with X-ray

1.7

9.5

179

1082

A91

ICPC

Abnormal result investigation NOS

1.3

9.4

636

4901

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

1.4

9.4

385

2745

QCE99, ,

SPAT

2.8

9.4

161

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

1.3

9.4

664

5151

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

1.3

9.4

703

5495

H58.8*A69.2

ICD-10 Finland

Ophthalmopathy in Lyme disease

+∞

9.4

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

1.3

9.4

812

6463

S01

ICPC

Pain/tenderness of skin

1.3

9.4

556

4210

SPAT1216

SPAT

Assessment of functional ability

0.8

9.4

1273

15150

188

Kela drug reimbursment

Psychosis requiring demanding treatment

0.2

9.3

620

SPAT1305

SPAT

Counselling and guidance related to physical exercise

0.8

9.3

688

8749

C09BA02

ATC

enalapril and diuretics; systemic

0.8

9.3

518

6836

U07

ICPC

Urine symptom/complaint other

1.2

9.3

1056

8670

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

0.5

9.2

1606

X59

ICD-10 Finland

Exposure to unspecified factor

1.2

9.2

2464

21790

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

0.6

9.2

188

2976

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.3

9.2

848

6802

H00.00

ICD-10 Finland

Hordeolum

1.3

9.2

548

4154

L50

ICD-10 Finland

Urticaria

1.6

9.1

201

1262

NH3EA

NOMESCO Finland

Feet X-ray examination with load

0.5

9.1

1614

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

1.8

9.1

136

770

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

0.5

9.1

1785

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.2

9.1

1373

11587

SPAT1059

SPAT

Spirometry at the office

0.7

9.1

306

4379

R053, ,

ICD-10 Finland

1.4

9.1

422

3076

B03XA02

ATC

darbepoetin alfa; parenteral

0.5

9.1

1436

A12AA04

ATC

calcium carbonate; oral

0.4

9.1

969

I20.81

ICD-10 Finland

Other angina pectoris stenosed coronary artery

0.7

9.1

393

5387

S97

ICPC

Chronic ulcer skin

0.7

9.0

409

5569

A26.0

ICD-10 Finland

Cutaneous erysipeloid

8.3

9.0

DAX08

NOMESCO Finland

Fitting of hearing aid

1.3

9.0

616

4756

ZXE20

NOMESCO Finland

More than three and less than five hours

0.8

9.0

1106

13296

D06BB03

ATC

aciclovir; topical

1.3

9.0

534

4043

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.2

9.0

2374

20974

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

1.3

9.0

628

4865

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.3

9.0

758

6015

A10BK01

ATC

dapagliflozin; oral

0.8

9.0

621

7961

R50.9

ICD-10 Finland

Fever, unspecified

1.2

9.0

1859

16125

U02

ICPC

Urinary frequency/urgency

1.2

9.0

1957

17045

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.4

8.9

442

3255

Z49.1

ICD-10 Finland

Extracorporeal dialysis

0.3

8.9

826

A11CC03

ATC

alfacalcidol; systemic

0.5

8.9

1641

R07.0

ICD-10 Finland

Pain in throat

1.2

8.9

885

7157

Z25.1

ICD-10 Finland

Need for immunization against influenza

0.7

8.9

371

5119

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.2

8.9

2393

21165

R12

ICD-10 Finland

Heartburn

1.2

8.9

1072

8851

F20.10

ICD-10 Finland

Raise schizophrenia continuously

0.0

8.9

254

N05AB03

ATC

perphenazine; systemic, rectal

0.6

8.9

170

2732

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

0.3

8.9

793

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

0.6

8.9

137

2320

TPX10

NOMESCO Finland

Implantation of vascular injection port

0.6

8.9

147

2444

S83

ICD-10 Finland

Dislocation, sprain and strain of joints and ligaments of knee

1.5

8.9

242

1597

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.2

8.9

2013

17587

Z34.8

ICD-10 Finland

Supervision of other normal pregnancy

1.2

8.8

1162

9681

N01

ICPC

Headache

1.2

8.8

1360

11503

J01FA09

ATC

clarithromycin; systemic

1.1

8.8

4276

39264

RF210, ,

NOMESCO Finland

0.6

8.8

121

2112

A10AA01, ,

ATC

0.5

8.8

1777

C08CA01

ATC

amlodipine; oral

0.9

8.8

4373

47424

A10AD05

ATC

insulin aspart; parenteral

0.3

8.7

846

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

0.4

8.7

1221

EBA05, ,

SPAT

1.6

8.7

189

1184

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

0.6

8.7

120

2092

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

1.5

8.7

228

1493

C09CA06

ATC

candesartan; oral

1.1

8.6

3274

29621

R01BA01

ATC

phenylpropanolamine; oral

1.3

8.6

605

4692

M54.5

ICD-10 Finland

Low back pain

1.1

8.6

5204

48350

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

1.4

8.5

341

2424

L20

ICPC

Joint symptom/complaint NOS

1.3

8.5

469

3512

NK4EA

NOMESCO Finland

Joint X-ray examintion with load or wrench not elsewhere classified

2.0

8.5

477

C07AB07

ATC

bisoprolol; oral

0.9

8.5

5748

61381

T89

ICPC

Diabetes insulin dependent

0.7

8.5

214

3236

G04BD12

ATC

mirabegron; oral

1.2

8.5

1469

12551

CA1TM

NOMESCO Finland

Calculation of intraocular lens power

0.5

8.5

1264

R03AC03

ATC

terbutaline; inhalant

1.2

8.5

1688

14591

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

1.7

8.5

141

825

-1, ,

ICPC

0.6

8.5

199

3052

DHB50

NOMESCO Finland

Turbinoplasty

1.5

8.5

282

1939

C07AB02

ATC

metoprolol; systemic

0.9

8.4

1696

19526

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.2

8.4

2075

18234

FN1BC

NOMESCO Finland

Extensive angiography of hear and/or coronary arteries

0.7

8.4

241

3552

A84.9

ICD-10 Finland

Tick-borne viral encephalitis, unspecified

7.3

8.4

FN1YT

NOMESCO Finland

Percutaneous insertion of coronary artery stent

0.7

8.4

232

3444

R03DC03

ATC

montelukast; oral

1.2

8.4

2147

18922

PE1AT

NOMESCO Finland

Femoral artery PTA

0.3

8.4

704

N05BA02

ATC

chlordiazepoxide; systemic

0.5

8.4

1644

N84.0

ICD-10 Finland

Polyp of corpus uteri

1.2

8.4

899

7338

C01AA05

ATC

digoxin; systemic

0.7

8.4

350

4821

SPAT1104

SPAT

Monitoring of emergency patient

0.7

8.3

428

5713

F20

ICD-10 Finland

Schizophrenia

0.2

8.3

380

N05AX12

ATC

aripiprazole; systemic

0.7

8.3

210

3171

201

Kela drug reimbursment

Chronic cardiac insufficiency

0.7

8.3

254

3694

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.2

8.3

812

6560

NH1BG

NOMESCO Finland

Ankle and foot MRI examination with high intensity magnet

1.5

8.3

254

1720

WX872

NOMESCO Finland

Intensive care

0.7

8.2

306

4300

L89

ICD-10 Finland

Decubitus ulcer and pressure area

0.4

8.2

1151

R23.3

ICD-10 Finland

Spontaneous ecchymoses

1.5

8.2

241

1616

AN2

Balloon angioplasty, including several vessels

0.6

8.2

1790

N06DX01

ATC

memantine; oral

0.7

8.2

348

4782

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

1.5

8.2

213

1393

PEF23

NOMESCO Finland

Thrombendarterectomy of femoral artery

0.4

8.2

906

R22.4

ICD-10 Finland

Localized swelling, mass and lump, lower limb

1.4

8.1

315

2228

R22.3

ICD-10 Finland

Localized swelling, mass and lump, upper limb

1.5

8.1

266

1823

HAMTE, ,

NOMESCO Finland

0.2

8.1

529

L50.9

ICD-10 Finland

Urticaria, unspecified

1.3

8.1

443

3317

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.2

8.1

1037

8619

WF049

NOMESCO Finland

Radiotherapy of metastasis

0.6

8.1

190

2912

TNG10

NOMESCO Finland

Puncture of knee

1.7

8.1

136

799

M54.2

ICD-10 Finland

Cervicalgia

1.2

8.1

994

8229

K80

ICPC

Cardiac arrhythmia NOS

1.2

8.1

1067

8896

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

0.8

8.1

496

6455

NA3BG, ,

SPAT

1.3

8.1

492

3744

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

0.7

8.1

195

2970

R06AE09

ATC

levocetirizine; oral

1.2

8.0

1790

15612

H3601, E113,

ICD-10 Finland

0.3

8.0

795

S72.0

ICD-10 Finland

Fracture of neck of femur

0.6

8.0

143

2331

DM1QA, ,

SPAT

1.3

8.0

479

3635

S80.0

ICD-10 Finland

Contusion of knee

1.2

8.0

935

7700

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

0.5

8.0

1289

SPAT1281

SPAT

Other administrative function

0.8

8.0

562

7185

L03

ICD-10 Finland

Cellulitis

1.8

8.0

123

705

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.2

8.0

1161

9769

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

1.6

8.0

162

1000

B35

ICD-10 Finland

Dermatophytosis

1.9

8.0

496

L60.9

ICD-10 Finland

Nail disorder, unspecified

1.6

8.0

198

1282

ZXC60

NOMESCO Finland

Application of heat

1.6

8.0

172

1078

M01AG02

ATC

tolfenamic acid; oral, rectal

1.2

8.0

1872

16395

C01DA14

ATC

isosorbide mononitrate; oral

0.8

7.9

1012

12121

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

1.3

7.9

573

4461

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

0.5

7.9

1353

L50.0

ICD-10 Finland

Allergic urticaria

1.4

7.9

297

2089

KE1BG

NOMESCO Finland

MRI of prostate

1.9

7.9

518

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.1

7.9

2174

19251

B01AA03

ATC

warfarin; systemic

0.8

7.9

1399

16276

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.3

7.9

707

5653

127

Kela drug reimbursment

Transplant complication

0.4

7.9

1117

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

1.8

7.9

117

664

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

1.6

7.8

171

1074

S83.2

ICD-10 Finland

Tear of meniscus, current

1.2

7.8

824

6710

EB4VA, ,

NOMESCO Finland

1.1

7.8

2311

20564

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

0.8

7.8

810

9907

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

0.5

7.8

1532

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

0.6

7.8

117

1994

R05

ICPC

Cough

1.1

7.8

3451

31484

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

0.6

7.8

172

2671

Z13.1

ICD-10 Finland

Special screening examination for diabetes mellitus

0.6

7.8

109

1889

R1100, ,

SPAT

0.4

7.8

999

Z75.2

ICD-10 Finland

Other waiting period for investigation and treatment

1.8

7.7

103

565

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

0.7

7.7

244

3527

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.3

7.7

456

3454

WW500

NOMESCO Finland

Blood transfusion

0.7

7.7

221

3253

I49.1

ICD-10 Finland

Atrial premature depolarization

1.3

7.7

433

3256

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.2

7.7

933

7712

D82

ICPC

Teeth/gum disease

1.1

7.7

5268

49184

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.3

7.7

509

3918

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.2

7.7

1156

9756

TUPAE, ,

NOMESCO Finland

3.9

7.7

WVA20, ,

SPAT

0.7

7.7

209

3106

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.2

7.7

859

7044

R95

ICPC

Chron obstructive pulmonary disease

0.6

7.7

139

2256

PD4AC

NOMESCO Finland

Arterigography of lower extremity with X-ray

0.4

7.7

820

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

0.8

7.6

1079

12797

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

0.6

7.6

102

1789

WX730

NOMESCO Finland

Conventional respirator

0.4

7.6

1033

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

0.6

7.6

122

2040

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.1

7.6

4541

42106

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

1.9

7.6

469

160

Kela drug reimbursment

exenatide

0.5

7.6

1451

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

0.5

7.6

1278

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

1.4

7.6

346

2520

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

0.6

7.6

167

2591

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.2

7.6

813

6639

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

0.6

7.6

119

1999

R03BB04

ATC

tiotropium bromide; inhalant

0.8

7.5

745

9155

ND1BG

NOMESCO Finland

Wrist and hand MRI examination with high intensity magnet

1.6

7.5

149

914

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

1.4

7.5

328

2370

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

1.4

7.5

341

2480

GA4YT

NOMESCO Finland

Puncture of pleura with ultrasound guidance

0.6

7.5

141

2271

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

0.6

7.5

157

2467

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

0.2

7.5

394

B05DB

ATC

Hypertonic solutions

0.2

7.5

395

N02AA01

ATC

morphine; systemic, rectal

0.5

7.5

1083

AB5BT

NOMESCO Finland

Blockage of nerv root with X-ray guidance

0.2

7.5

567

N05AH04

ATC

quetiapine; oral

0.9

7.5

1680

19188

E03

ICD-10 Finland

Other hypothyroidism

1.2

7.5

728

5879

UJD10, ,

SPAT

1.4

7.5

304

2171

DFF59

NOMESCO Finland

Other assessment of balance

1.8

7.5

114

652

WX290, ,

SPAT

1.4

7.5

377

2790

D07AC01

ATC

betamethasone; topical

1.1

7.5

5014

46754

NHQ40

NOMESCO Finland

Amputation of toe

0.4

7.5

926

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.2

7.5

1324

11338

F51.0

ICD-10 Finland

Nonorganic insomnia

1.1

7.5

2168

19270

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

1.3

7.5

408

3057

U09

ICD-10 Finland

Post COVID-19 condition

1.8

7.5

102

565

N05AF05

ATC

zuclopenthixol; systemic

0.3

7.5

612

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.2

7.4

839

6885

UJH02

NOMESCO Finland

Anoscopy

1.3

7.4

459

3501

PD3AT

NOMESCO Finland

Pelvic artery PTA

0.2

7.4

334

WX320

NOMESCO Finland

Spinalanesthesy

1.1

7.4

3203

29189

KED22

NOMESCO Finland

Transurethral resection of prostate

1.3

7.4

430

3254

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

0.2

7.3

526

R19.4

ICD-10 Finland

Change in bowel habit

1.4

7.3

338

2466

K05.1

ICD-10 Finland

Chronic gingivitis

1.2

7.3

803

6573

F10.20

ICD-10 Finland

Alcohol dependence currently independent

0.5

7.3

1393

Z09.4

ICD-10 Finland

Follow-up examination after treatment of fracture

1.3

7.3

625

4975

R01AD05

ATC

budesonide; nasal

1.2

7.3

861

7101

NB2AT, ,

SPAT

1.8

7.3

526

R49.03

ICD-10 Finland

Atrophic dysphonia

1.7

7.3

125

740

M20.2

ICD-10 Finland

Hallux rigidus

1.4

7.3

360

2658

SPAT1311

SPAT

Counselling and guidance related to occupational health

1.4

7.3

332

2420

C02EA02, ,

ATC

0.6

7.2

161

2493

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

0.2

7.2

386

H66.9

ICD-10 Finland

Otitis media, unspecified

1.2

7.2

718

5813

NH1BG, ,

SPAT

1.5

7.2

188

1232

WZC30

NOMESCO Finland

Teaching

0.9

7.2

1700

19342

L29

ICD-10 Finland

Pruritus

1.6

7.2

167

1067

177

Kela drug reimbursment

Insulin glargine 300 U / ml

0.5

7.2

1358

ND1AA, ,

SPAT

1.4

7.2

328

2392

XQ800

NOMESCO Finland

Prick test

1.2

7.1

857

7079

EB1CA, ,

SPAT

1.8

7.1

551

N02CC03

ATC

zolmitriptan; nasal, oral

1.3

7.1

608

4837

K40

ICD-10 Finland

Inguinal hernia

1.5

7.1

221

1502

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

0.4

7.1

949

H3603, E103,

ICD-10 Finland

0.3

7.1

595

ND2AA, ,

SPAT

1.3

7.1

646

5179

R56.8

ICD-10 Finland

Other and unspecified convulsions

0.7

7.1

295

4063

PD4DE

NOMESCO Finland

Lower extremity artery ultrasound examination with Doppler method

0.5

7.1

1261

C07FB02

ATC

metoprolol and felodipine; systemic

0.6

7.1

117

1941

A03FA01

ATC

metoclopramide; systemic, rectal

0.9

7.0

2404

26697

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.2

7.0

814

6699

SPD00

NOMESCO Finland

Mucosa borne complete denture

0.3

7.0

684

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

0.2

7.0

360

Z04

ICD-10 Finland

Examination and observation for other reasons

1.6

7.0

171

1104

WX702

NOMESCO Finland

Supraglottic ventilation device

0.8

7.0

428

5570

H81.3

ICD-10 Finland

Other peripheral vertigo

1.4

7.0

312

2265

J01DC02

ATC

cefuroxime; systemic

1.3

7.0

609

4858

CKD94

NOMESCO Finland

Combined vitrectomy and procedure on lens through pars plana

1.6

7.0

152

956

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.2

7.0

1002

8423

C34.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bronchus and lung

0.2

7.0

341

SPAT1352

SPAT

Inspection, maintenance and instruction for use of hearing aid

0.3

7.0

604

F16

ICPC

Eyelid symptom/complaint

1.3

7.0

614

4906

R01AD59

ATC

mometasone, combinations; nasal

1.2

6.9

771

6320

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

0.3

6.9

633

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

0.2

6.9

321

E66.9

ICD-10 Finland

Obesity, unspecified

0.7

6.9

213

3090

OAB48, ,

SPAT

1.1

6.9

2012

17882

E0000UV, ,

ATC

1.1

6.9

5845

55049

H40.1

ICD-10 Finland

Primary open-angle glaucoma

2.5

6.9

159

E66.8

ICD-10 Finland

Other obesity

0.8

6.9

418

5444

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

0.4

6.9

721

NH1AA, ,

SPAT

1.3

6.9

363

2707

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

0.6

6.9

126

2036

E87.5

ICD-10 Finland

Hyperkalaemia

0.5

6.9

1140

RTGOM, ,

NOMESCO Finland

3.0

6.9

N05CD07

ATC

temazepam; oral

0.8

6.9

856

10270

O35.1

ICD-10 Finland

Maternal care for (suspected) chromosomal abnormality in fetus

1.5

6.9

180

1182

XQ855, ,

SPAT

0.4

6.8

877

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

0.3

6.8

550

XA402

NOMESCO Finland

ENMG

1.4

6.8

272

1938

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

0.8

6.8

652

8038

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

1.3

6.8

422

3222

WYA20

NOMESCO Finland

Home visit

0.5

6.8

1001

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.1

6.8

2197

19659

E86

ICD-10 Finland

Volume depletion

0.6

6.8

1542

N07BA03

ATC

varenicline; oral

0.7

6.8

331

4447

H00.1

ICD-10 Finland

Chalazion

1.3

6.8

441

3389

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.2

6.8

1029

8693

K59.1

ICD-10 Finland

Functional diarrhoea

1.2

6.8

648

5226

NHL14

NOMESCO Finland

Shortening or lengthening of achilles tendon

0.2

6.8

466

C10AA07

ATC

rosuvastatin; oral

1.1

6.8

4765

44491

ITSEH, ,

NOMESCO Finland

0.2

6.8

294

M19.8

ICD-10 Finland

Other specified arthrosis

1.3

6.8

471

3654

J33.8

ICD-10 Finland

Other polyp of sinus

1.5

6.8

219

1502

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.2

6.8

1300

11209

XX1XN

NOMESCO Finland

Other isotope examination

0.3

6.8

562

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

0.4

6.8

801

J02

ICD-10 Finland

Acute pharyngitis

1.3

6.7

371

2785

I11.0

ICD-10 Finland

Hypertensive heart disease with (congestive) heart failure

0.6

6.7

1538

SFA20

NOMESCO Finland

Two-surface restoration

1.1

6.7

8752

83942

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.2

6.7

648

5232

H90.4

ICD-10 Finland

Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

1.3

6.7

436

3352

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.2

6.7

805

6653

XX2RW, ,

NOMESCO Finland

0.5

6.7

1076

V03AE01

ATC

polystyrene sulfonate; oral

0.4

6.7

740

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.2

6.7

1304

11256

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.2

6.7

940

7890

J31

ICD-10 Finland

Chronic rhinitis, nasopharyngitis and pharyngitis

1.6

6.7

132

812

G03DC05

ATC

[U] tibolone

1.3

6.7

490

3830

M25.9

ICD-10 Finland

Joint disorder, unspecified

1.7

6.6

115

683

U01

ICPC

Dysuria/painful urination

1.2

6.6

955

8031

H57.1

ICD-10 Finland

Ocular pain

1.3

6.6

447

3454

N76.0

ICD-10 Finland

Acute vaginitis

1.2

6.6

681

5537

G50.1

ICD-10 Finland

Atypical facial pain

1.5

6.6

199

1345

R4120

NOMESCO Finland

Occupational therapy

1.2

6.6

744

6109

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

0.9

6.6

3239

35248

T82

ICPC

Obesity

0.7

6.6

298

4048

OAB72

NOMESCO Finland

Weight control and weight loss guidance

0.3

6.6

616

N05AA01

ATC

chlorpromazine; systemic, rectal

0.4

6.6

807

KAY20, ,

NOMESCO Finland

1.6

6.6

137

853

H3603, E113,

ICD-10 Finland

0.2

6.6

457

SPA30

NOMESCO Finland

Grinding of a single crown and bridge pillar or a single post and crown

1.6

6.6

149

947

N95.1

ICD-10 Finland

Menopausal and female climacteric states

1.2

6.6

1678

14780

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

1.4

6.6

242

1701

H25.8

ICD-10 Finland

Other senile cataract

1.2

6.6

1116

9525

XFE00

NOMESCO Finland

Epicardial ultrasonography

0.6

6.6

1436

KAY40, ,

NOMESCO Finland

1.5

6.6

207

1413

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.3

6.6

353

2642

H53.9

ICD-10 Finland

Visual disturbance, unspecified

1.3

6.6

444

3433

C09CA01

ATC

losartan; oral

0.9

6.6

2782

30515

PD4CG

NOMESCO Finland

Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet

0.4

6.5

760

TK810

NOMESCO Finland

Hemofiltration

0.2

6.5

365

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

1.5

6.5

215

1481

Z50.0

ICD-10 Finland

Cardiac rehabilitation

0.3

6.5

580

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

0.4

6.5

700

137

Kela drug reimbursment

Uraemia requiring dialysis

0.3

6.5

517

H91.9

ICD-10 Finland

Hearing loss, unspecified

1.3

6.5

562

4484

E66.00

ICD-10 Finland

Metabolic syndrome

0.8

6.5

417

5385

N07BB01

ATC

disulfiram; oral

0.7

6.5

253

3515

L02

ICPC

Back symptom/complaint

1.2

6.4

1291

11168

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

1.4

6.4

227

1583

J01MA02

ATC

ciprofloxacin; systemic

1.1

6.4

5125

48103

B35.4

ICD-10 Finland

Tinea corporis

1.6

6.4

153

984

SPAT1251

SPAT

Organisation of medication

0.7

6.4

151

2306

DM1AI, ,

SPAT

1.8

6.4

475

XF610

NOMESCO Finland

Measurement of pulsvariation

3.2

6.4

R41.3

ICD-10 Finland

Other amnesia

1.4

6.4

289

2105

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

1.7

6.4

106

623

SAA01

NOMESCO Finland

Simple examination of mouth

1.1

6.4

11052

107165

R51.81

ICD-10 Finland

Facial pain NOS

1.4

6.4

264

1895

H25

ICD-10 Finland

Senile cataract

1.7

6.4

113

676

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

0.6

6.4

145

2230

Z34.0

ICD-10 Finland

Supervision of normal first pregnancy

1.2

6.4

893

7493

D22.7

ICD-10 Finland

Melanocytic naevi of lower limb, including hip

1.5

6.4

207

1422

J01FA06

ATC

roxithromycin; oral

1.1

6.4

5326

50095

WYA50

NOMESCO Finland

Student oral health check consistent with decree to assess need for oral health guidance and services

1.3

6.4

418

3220

P70

ICPC

Dementia

0.5

6.4

1228

C02AC05

ATC

moxonidine; oral

0.7

6.3

278

3792

D06BX02

ATC

ingenol mebutate; topical

1.7

6.3

114

685

G30.9

ICD-10 Finland

Alzheimer disease, unspecified

0.6

6.3

1484

SPAT1255

SPAT

Intravenous administration of medicine

0.8

6.3

474

6005

SDE04

NOMESCO Finland

Periodontal treatment by dental hygienist, very extensive

1.2

6.3

1121

9604

Z94.0

ICD-10 Finland

Kidney transplant status

0.4

6.3

734

S15

ICPC

Foreign body in skin

1.2

6.3

762

6305

I84

ICD-10 Finland

Hemorrhoids

1.4

6.3

277

2010

JA3AT

NOMESCO Finland

Cathetrisation of abdominal cavity with ultrasound guidance

0.5

6.3

1327

H53

ICD-10 Finland

Visual disturbances

1.7

6.3

103

604

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

0.5

6.3

1287

R52.0

ICD-10 Finland

Acute pain

1.3

6.3

353

2662

NB1DG, ,

SPAT

1.6

6.2

128

795

1048X

ICD-9 Finland

Other spirochaetal infection, Other specified spirochaetal infections[INFECTIO SPIROCHAETALES ALIA DEFINITA]

+∞

6.2

A10AD01

ATC

insulin (human); parenteral

0.4

6.2

871

S63.6

ICD-10 Finland

Sprain and strain of finger(s)

1.3

6.2

401

3081

EBA30

NOMESCO Finland

Extraction of root of tooth

0.8

6.2

411

5289

R03.0

ICD-10 Finland

Elevated blood-pressure reading, without diagnosis of hypertension

1.3

6.2

536

4274

G01AA10

ATC

clindamycin; vaginal

1.1

6.2

1792

15916

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

1.5

6.2

157

1024

I25.2

ICD-10 Finland

Old myocardial infarction

0.7

6.2

309

4134

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.2

6.2

679

5563

64199

ICD-8 Finland

Abortion induced for other legal indications, Without mention of sepsis or toxaemia

0.8

6.2

456

5787

G03DA04

ATC

progesterone; systemic, rectal, vaginal

1.3

6.2

370

2815

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

0.5

6.2

1268

M01AC06

ATC

meloxicam; systemic, rectal

1.1

6.2

4946

46421

N64.4

ICD-10 Finland

Mastodynia

1.3

6.2

379

2894

NDJ40

NOMESCO Finland

Closed reduction of fracture of wrist or hand

1.7

6.1

113

683

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.2

6.1

1500

13171

XQ899

NOMESCO Finland

Other assessment of skin

2.1

6.1

258

D11

ICPC

Diarrhoea

1.2

6.1

1462

12819

WZC00, ,

SPAT

0.9

6.1

1553

17582

ULC02

NOMESCO Finland

Hysteroscopy

1.3

6.1

567

4562

C50

ICD-10 Finland

Malignant neoplasm of breast

1.4

6.1

283

2072

D07AC13

ATC

mometasone; topical

1.1

6.1

3769

34951

L71

ICD-10 Finland

Rosacea

1.4

6.1

299

2209

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

0.3

6.1

528

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

0.5

6.1

1091

SPAT1053

SPAT

Memory test

0.8

6.1

1045

12181

Z3232

NOMESCO Finland

Midwife

1.2

6.1

636

5186

SPAT1240

SPAT

Therapeutic discussion

0.8

6.0

846

10039

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

0.6

6.0

126

1973

F20.5

ICD-10 Finland

Residual schizophrenia

0.2

6.0

330

K03.80

ICD-10 Finland

Irradiated enamel

1.2

6.0

654

5353

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

0.4

6.0

631

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

0.2

6.0

271

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

0.6

6.0

1296

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

1.3

6.0

363

2766

D06

ICPC

Abdominal pain localized other

1.2

6.0

1116

9599

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

4423

10522

5.32

307.65

3.2

2.3

29.12

18.85

au/ml

13.85

971

983

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

3972

9800

4.98

307.65

1.7

1.2

62.66

43.81

au/ml

8.29

787

413

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

412

469

8.98

307.65

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

420

543

7.90

303.87

1.1

994.09

307.72

ng/l

1.17

125

140

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

406

629

6.59

249.18

1.1

0.11

0.99

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

3112

18680

1.81

175.85

5.1

5.0

32.94

32.36

1.95

1813

12731

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

549

1605

3.50

155.01

1.1

31.99

4.70

au/ml

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

225

357

6.37

134.83

1.0

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

483

1429

3.45

133.78

1.1

—

(40761536) Microorganisms panel - Urine sediment

460

12854

0.34

120.91

4.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

862

4050

2.19

96.00

1.2

1.4

567.28

531.38

mg/l

1.23

838

3868

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

797

15892

0.48

90.91

2.5

3.4

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

578

12962

0.43

90.42

2.8

3.9

1.23

mmol/l

1.09

514

11212

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

15535

145832

1.73

88.14

13.6

15.7

82.69

81.91

ml/min/173m2

6.38

14192

135171

(3019225) pH of Specimen

2255

14856

1.60

83.93

3.6

4.3

7.37

7.36

0.55

1375

10773

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

755

3578

2.16

82.09

1.2

1.3

3.51

3.76

mmol/l

11.89

710

3393

(3000963) Hemoglobin [Mass/volume] in Blood

16855

163506

3.51

79.37

22.1

24.8

136.41

135.28

g/l

25.96

16677

162067

(3007461) Platelets [#/volume] in Blood

16847

163418

3.42

78.65

22.0

24.7

248.61

254.22

e9/l

28.42

16483

160362

(3026361) Erythrocytes [#/volume] in Blood

16850

163478

3.44

78.36

22.0

24.6

4.52

4.49

e12/l

9.87

16395

159921

(3035941) MCH [Entitic mass]

16848

163459

3.42

78.12

21.9

24.5

30.39

30.31

8.85

16668

161995

(3024731) MCV [Entitic mean volume] in Red Blood Cells

16848

163464

3.41

78.02

21.9

24.6

91.19

91.08

3.05

16666

162002

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

16848

163472

3.41

77.85

22.4

25.1

41.01

40.87

0.18

16665

161953

(3010813) Leukocytes [#/volume] in Blood

16848

163498

3.40

77.31

22.0

24.7

6.36

6.69

e9/l

52.32

16433

159893

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

113

158

7.19

76.33

1.0

1.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

16493

159024

2.11

67.61

12.3

12.6

25.68

26.36

u/l

5.90

15971

154977

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

312

1110

2.84

63.15

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

334

1236

2.74

62.75

1.2

53.46

40.03

mg/l

2.86

318

1029

(3017181) Myelocytes/Leukocytes in Blood

872

15115

0.55

61.94

4.3

4.5

0.86

0.95

0.38

292

4529

(3023410) Appearance of Cerebral spinal fluid

388

1579

2.49

60.10

1.3

1.6

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

323

1205

2.71

59.75

1.1

318.18

257.16

mg/l

3.92

309

1057

(3021440) Promyelocytes/Leukocytes in Blood

841

14471

0.56

57.93

4.4

4.6

0.11

0.12

0.15

264

3901

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

15900

152255

1.65

57.58

6.0

5.9

2.79

2.74

mmol/l

11.75

14702

142757

(3002179) Metamyelocytes/Leukocytes in Blood

842

14426

0.56

57.05

4.2

4.4

0.70

0.72

0.08

308

4316

(3025159) Blasts/Leukocytes in Blood

859

14632

0.57

56.98

4.6

4.8

0.06

0.36

4.49

253

3731

(3047181) Lactate [Moles/volume] in Blood

135

4851

0.27

55.97

3.2

5.9

1.24

1.30

mmol/l

0.42

124

4290

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

15658

149580

1.57

54.98

5.3

5.1

1.53

1.48

mmol/l

49.02

14472

139979

(3010421) pH of Blood

160

5174

0.30

54.65

3.0

3.6

7.41

0.18

160

5114

(3020564) Creatinine [Moles/volume] in Serum or Plasma

16496

159838

1.96

54.45

18.3

20.9

74.04

75.81

umol/l

20.48

16263

158263

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

4810

39032

1.32

54.36

2.2

2.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

3613

45546

0.74

54.29

2.7

3.4

0.93

0.24

estimate

0.72

687

14157

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

15718

150395

1.57

53.49

5.2

4.76

4.68

mmol/l

20.67

14597

141529

(3029937) Albumin [Presence] in Urine by Test strip

3728

46683

0.74

53.30

3.7

4.2

0.00

estimate

4.59

837

16441

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

308

7212

0.42

52.51

3.1

5.1

1.49

1.63

1.82

297

6831

(3007930) Methemoglobin/Hemoglobin.total in Blood

264

6570

0.39

52.07

3.4

5.4

0.83

0.88

0.76

256

6207

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2476

32849

0.71

50.76

1.5

1.7

25380159.31

33319232.88

pmol/l

0.35

2041

27516

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

311

1237

2.54

50.61

1.2

1.3

1.91

2.14

mmol/l

3.89

283

1155

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

3554

27903

1.35

49.57

2.9

3.0

0.83

1.23

e6/l

2.88

1808

14762

(3008152) Bicarbonate [Moles/volume] in Arterial blood

522

9799

0.52

47.83

6.6

7.2

24.68

24.59

mmol/l

0.32

513

9383

(3011397) Hemoglobin [Presence] in Urine by Test strip

4690

38473

1.30

47.60

3.5

3.8

0.29

0.32

—

361

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

3201

24949

1.35

46.43

3.5

3.2

0.72

0.76

ug/l

1.52

2057

16302

(3033658) Prothrombin time (PT) actual/Normal

4923

40774

1.29

46.11

3.6

4.2

92.43

91.12

3.53

4818

39859

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

235

856

2.77

45.61

1.1

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

12519

116207

1.29

44.51

4.7

4.5

10.07

11.98

mm/h

61.85

11654

109292

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

14980

142709

1.41

44.46

4.4

1.22

1.30

mmol/l

39.89

13662

132326

(3035320) C reactive protein [Mass/volume] in Body fluid

293

1212

2.44

43.90

3.0

2.7

24.77

27.87

mg/l

0.78

210

877

(3018572) Chloride [Moles/volume] in Blood

3342

0.24

41.81

3.8

7.0

104.96

105.10

mmol/l

0.14

3007

(3039000) Anion gap in Blood by calculation

3341

0.24

41.79

3.8

7.0

11.42

11.18

mmol/l

0.31

3005

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2352

17732

1.38

41.72

5.1

6.7

—

(3027315) Oxygen [Partial pressure] in Blood

3335

0.25

40.66

3.3

3.9

8.86

8.70

kpa

0.47

3266

(3013290) Carbon dioxide [Partial pressure] in Blood

3312

0.26

40.18

3.3

3.9

5.02

5.00

kpa

0.11

3244

(3012501) Base excess in Blood by calculation

3310

0.26

40.14

3.3

3.9

1.94

2.46

mmol/l

1.94

2259

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

384

1848

2.10

40.08

1.8

2.1

21.08

25.63

mg/l

0.96

724

(40768443) Skin Pathology biopsy report

1129

7460

1.55

39.98

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

14978

143157

1.38

39.37

5.9

6.4

37.86

39.17

mmol/mol

103.11

13777

134786

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

632

3625

1.77

38.97

1.3

1.5

255.25

2574.23

e6/l

1.51

459

2856

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

15628

150517

1.45

38.91

14.0

16.2

22.41

23.67

mg/l

4.66

12408

124127

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

207

769

2.71

38.75

1.2

1.6

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

3561

28856

1.30

38.09

1.4

1.3

11.59

11.84

u/ml

0.07

1179

11398

(3014051) Protein [Presence] in Urine by Test strip

5333

45411

1.25

37.94

2.8

2.9

0.00

0.07

8.28

984

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

5507

63463

0.80

36.22

3.3

3.9

2.19

0.45

estimate

0.79

693

14487

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2228

17008

1.36

36.09

2.0

3.36

3.47

ratio

3.72

1736

13110

(3006462) Nitrate [Presence] in Urine

181

652

2.80

35.98

4.1

3.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

7802

69550

1.22

35.41

2.2

2.1

100.91

97.18

pmol/l

8.32

3744

36789

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

612

3576

1.74

35.37

1.2

1.4

35.82

38.93

e6/l

0.11

422

2632

(1616796) Gas panel - Central venous blood

120

3583

0.33

35.01

3.1

3.8

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

701

4264

1.67

34.94

1.2

3.93

3.80

0.13

587

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3785

31220

1.27

34.66

1.4

1.3

34.14

33.22

iu/ml

0.10

1053

9584

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

3131

25421

1.28

32.23

3.0

3.1

2.30

2.87

e6/l

2.20

1376

12235

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

14812

142055

1.32

32.10

5.7

5.6

1.89

mu/l

0.22

13510

132498

(3037522) Nuclear Ab [Titer] in Serum

2945

23738

1.29

32.07

1.4

475.36

524.68

titre

0.82

629

5108

(4211845) Urine protein measurement

185

718

2.59

31.84

4.0

3.0

—

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

188

4.22

30.14

1.2

1.3

79.00

50.99

6.34

(3007164) IgA [Mass/volume] in Serum or Plasma

3919

32900

1.25

30.14

1.5

2.30

2.41

g/l

2.60

2122

20451

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

752

4851

1.58

29.50

1.3

3.20

8.09

u/ml

5.58

720

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

752

4858

1.57

29.31

1.3

2.16

5.89

u/ml

2.00

475

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

189

773

2.46

29.19

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

15131

145878

1.33

29.06

5.3

5.2

5.75

5.92

mmol/l

84.80

13786

135260

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1665

12553

1.36

28.82

1.7

3.49

mmol/l

0.02

1164

8612

(3004616) Nuclear Ab [Presence] in Serum

392

2149

1.84

28.15

1.4

1.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

874

5898

1.51

27.91

1.8

1.7

—

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

5.48

27.62

1.1

1.2

7.00

26.05

1.85

(3035715) Granulocytes [#/volume] in Blood

109

3037

0.35

27.61

3.7

3.4

3.76

4.05

e9/l

1.08

109

3032

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

787

5224

1.53

27.16

1.3

38.72

40.56

u/ml

0.05

285

(36660697) Celiac disease serology panel - Serum

1738

13311

1.34

27.04

1.2

—

(3018010) Neutrophils/Leukocytes in Blood

8290

75487

1.19

26.82

6.7

6.6

55.64

57.10

26.66

7760

72298

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

307

1584

1.96

26.56

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

117

393

2.99

26.55

1.1

—

(3026782) Osmolality of Urine

2444

30025

0.78

26.31

2.5

3.0

549.16

526.59

mosm/kgh2o

5.51

2023

26396

(3023420) DNA double strand Ab [Units/volume] in Serum

1004

7089

1.44

25.45

1.7

1.8

8.47

7.17

iu/ml

0.51

202

1715

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

638

4108

1.57

25.24

1.2

1.3

1.16

4.23

u/ml

2.92

271

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

178

764

2.34

24.78

1.4

1.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

113

388

2.93

24.69

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

111

383

2.91

24.06

1.1

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

324

1760

1.86

24.02

1.2

30.94

46.24

u/ml

0.35

100

(3020682) Albumin/Creatinine [Ratio] in Urine

4678

53254

0.83

23.80

3.7

4.2

6.05

8.38

mg/mmol

1.58

2587

32629

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

651

4274

1.54

23.64

1.3

14.26

14.23

u/ml

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1959

15550

1.29

23.37

2.3

2.6

37.27

49.48

u/l

1.36

1659

13214

(3023103) Potassium [Moles/volume] in Serum or Plasma

15787

153776

1.36

23.23

15.8

18.9

3.95

3.96

mmol/l

7.84

15405

150798

(3037467) Urinalysis macro (dipstick) panel - Urine

11290

106207

1.19

23.20

4.5

4.6

1.68

2.39

0.90

163

(3019550) Sodium [Moles/volume] in Serum or Plasma

15756

153456

1.35

22.96

15.6

18.7

139.92

139.71

mmol/l

25.40

15411

150723

(3044640) Blood type and Crossmatch panel - Blood

5775

51427

1.19

22.89

2.2

2.5

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

427

6926

0.61

22.69

2.5

3.5

25.27

25.29

mmol/l

0.03

421

6704

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

451

2740

1.66

22.65

1.1

16.73

14.28

au/ml

0.22

104

666

(3048689) Calprotectin [Mass/mass] in Stool

2606

21516

1.25

22.37

2.3

2.4

110.04

133.28

ug/g

3.12

1989

17163

(3013650) Neutrophils [#/volume] in Blood by Automated count

9796

91250

1.17

22.01

9.1

10.2

3.73

4.09

e9/l

45.82

8266

79360

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

8020

73551

1.17

21.87

2.4

2.5

79.27

1297.29

nmol/l

0.50

7063

67228

(3006315) Basophils [#/volume] in Blood

8867

81974

1.17

21.82

6.7

6.6

0.04

e9/l

1.64

7420

70646

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

11245

105961

1.18

21.82

3.3

3.4

40.61

47.93

u/l

20.08

10510

99942

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

255

1328

1.93

21.56

1.2

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

399

2380

1.69

21.51

1.2

2.25

12.82

u/ml

3.33

103

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

260

1365

1.92

21.47

1.2

—

(3001604) Monocytes [#/volume] in Blood

8839

81756

1.17

21.44

6.7

6.6

0.55

0.58

e9/l

39.32

7403

70477

(3013115) Eosinophils [#/volume] in Blood

9104

84406

1.17

21.42

6.8

0.19

e9/l

3.18

7784

73929

(3006504) Eosinophils/Leukocytes in Blood

8157

75017

1.17

21.18

6.8

2.92

2.85

2.32

7557

70516

(3000012) Reticulocyte production index

2225

0.34

21.15

2.2

2.1

0.94

0.92

0.14

1489

(3019069) Monocytes/Leukocytes in Blood

8176

75212

1.17

21.14

6.9

8.84

8.79

0.85

7582

70764

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

258

1363

1.91

20.92

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

260

1386

1.89

20.52

1.2

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

791

5562

1.44

20.49

2.6

2.5

0.73

0.80

g/l

0.25

689

4799

(3022806) Fractional oxyhemoglobin in Capillary blood

1855

0.29

20.47

1.8

91.20

89.90

0.91

1829

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

100

358

2.80

20.33

1.1

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

263

1415

1.87

20.18

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

260

4647

0.55

20.01

1.4

1.7

—

(3019198) Lymphocytes [#/volume] in Blood

8989

83493

1.16

19.98

6.7

6.6

1.93

e9/l

0.03

7708

73684

(3022096) Basophils/Leukocytes in Blood

8137

75021

1.16

19.93

6.9

0.73

0.69

9.14

7535

70480

(3027801) Oxygen [Partial pressure] in Arterial blood

1467

18618

0.77

19.89

7.0

8.1

13.51

12.55

kpa

7.59

1431

17962

(3018333) Ribosomal P Ab [Presence] in Serum

243

1283

1.91

19.76

1.2

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1469

18625

0.77

19.76

7.0

8.1

5.09

5.10

kpa

0.16

1431

17976

(3003396) Base excess in Arterial blood by calculation

1455

18469

0.77

19.75

7.0

8.0

0.48

0.94

mmol/l

5.71

1280

15381

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

247

1313

1.89

19.68

1.2

—

(3019977) pH of Arterial blood

1470

18624

0.77

19.65

7.0

8.1

7.43

7.42

2.76

584

10126

(3022145) Colonoscopy Study observation

2317

19142

1.24

19.55

1.4

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

666

4590

1.47

19.18

1.5

23.97

16.46

iu/ml

0.43

101

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

378

2294

1.66

19.13

1.1

3.69

2.44

0.48

375

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

884

11996

0.72

19.03

2.2

2.9

136.49

174.45

ng/l

4.71

798

10970

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

2099

0.36

19.02

2.3

2.1

33.30

32.62

0.97

2084

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

198

3.39

18.92

1.1

—

(3022621) pH of Urine by Test strip

1587

12594

1.29

18.78

2.5

2.6

6.00

6.06

1.92

880

8414

(3002030) Lymphocytes/Leukocytes in Blood

8307

76929

1.16

18.62

6.7

6.8

29.52

28.06

30.27

7812

73086

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

197

990

2.00

18.54

1.1

0.85

1.21

—

(3016502) Oxygen saturation in Arterial blood

1297

16582

0.76

18.52

7.4

8.4

95.86

95.69

0.35

1283

16025

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1206

15569

0.76

18.50

7.8

8.9

122.69

121.07

g/l

2.34

1198

15211

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

4729

42010

1.17

18.26

6.1

5.5

2.30

3.02

ug/l

3.15

4235

38258

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

614

4232

1.47

17.69

2.7

2.5

0.00

g/l

-0.00

570

3964

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

264

1486

1.79

17.57

1.2

79.30

79.96

u/ml

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1518

12093

1.28

17.37

2.3

13.72

13.02

nmol/l

2.69

1356

10952

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

286

1658

1.74

17.20

1.2

1.1

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1750

21376

0.80

17.08

4.4

6.2

1.02

1.04

mmol/l

2.16

1591

19995

(1761482) Bacteria [#/volume] in Urine by Culture

182

3447

0.52

17.08

4.1

—

(3000034) Microalbumin [Mass/volume] in Urine

1381

0.26

16.96

3.4

3.0

77.33

48.41

mg/l

0.20

989

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

773

5607

1.40

16.83

1.6

1.7

3.13

4.36

mg/l

3.30

556

4188

(3005988) Vibrio sp identified in Specimen by Organism specific culture

324

1955

1.67

16.82

1.4

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

3825

33590

1.18

16.74

4.5

21.70

21.88

0.30

1832

16351

(3012516) Albumin [Mass/volume] in Urine

4708

52428

0.86

16.63

3.3

3.5

34.24

45.92

mg/l

1.88

2671

32820

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

13178

126723

1.18

16.58

18.6

20.6

332.47

332.20

g/l

3.22

13129

126119

(3032080) INR in Blood by Coagulation assay

6605

71762

0.87

16.52

12.9

13.9

1.22

inr

0.01

4968

59738

(40762887) Creatinine [Moles/volume] in Blood

107

4.12

16.47

1.3

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

322

1953

1.66

16.40

1.4

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

218

3866

0.56

16.38

1.7

2.3

131.03

129.66

g/l

0.30

112

2945

(3020779) Urea [Moles/volume] in Serum or Plasma

1116

14315

0.76

16.24

5.1

7.9

8.02

9.56

mmol/l

14.80

1064

13749

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

183

3.29

16.18

1.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

680

9382

0.71

16.16

8.6

10.3

16.23

16.03

1.28

673

9058

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

7319

67585

1.15

16.15

1.8

1.9

1.27

1.37

mmol/l

25.65

6153

56849

(3025468) Yersinia sp identified in Specimen by Organism specific culture

320

1946

1.66

16.14

1.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

4010

35454

1.17

16.03

1.7

1.8

1.03

1.18

mg/l

1.82

2982

27590

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

640

4539

1.43

15.87

2.7

2.4

0.00

g/l

1.12

571

3974

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

850

6332

1.36

15.72

1.6

13.03

17.35

u/ml

1.29

160

1465

(3031040) Bacteria [#/volume] in Urine by Automated count

10703

101543

1.14

15.47

4.5

4.7

5380.30

1629.37

e6/l

0.70

1360

(3023368) Bacteria identified in Blood by Culture

3772

42542

0.85

15.46

3.6

4.5

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

559

3889

1.45

15.39

1.2

1.3

44.64

44.99

u/ml

0.01

366

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

184

3.21

15.37

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

659

4730

1.41

15.28

2.7

2.4

0.01

0.02

g/l

0.48

596

4254

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

7726

71775

1.14

15.24

5.4

6.8

1.22

1.21

mmol/l

17.95

7009

66727

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

594

4206

1.43

14.88

1.1

1.2

—

(3009508) Creatinine [Moles/volume] in Urine

5099

56126

0.87

14.86

3.2

3.5

7.64

7.49

mmol/l

1.63

4142

47728

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

818

6112

1.36

14.85

2.6

2.4

2.82

2.88

g/l

1.02

733

5582

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1904

15846

1.23

14.74

2.2

2.1

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

12513

120195

1.15

14.57

7.9

8.6

75.27

78.99

u/l

16.77

11775

114621

(3002256) Pathology report gross observation

2534

21708

1.20

14.53

1.3

—

(40758558) Short blood count panel - Blood

5349

48597

1.15

14.49

6.7

6.6

—

(44806420) Estimation of glomerular filtration rate

1855

0.41

14.49

2.2

2.5

—

(3021589) Normoblasts [#/volume] in Blood

6577

71043

0.88

14.23

9.1

11.8

0.00

e9/l

3.76

4947

58111

(42529406) Shigella sp [Presence] in Stool by Culture

595

4252

1.41

14.17

1.1

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

326

2061

1.59

14.12

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

593

4241

1.41

14.06

1.1

1.2

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

4970

54618

0.87

13.88

3.0

3.4

31.25

34.03

u/l

3.52

4681

51589

(3001019) Free T4 and TSH panel - Serum or Plasma

1008

7852

1.30

13.69

1.7

—

(3040151) Glucose [Moles/volume] in Capillary blood

1784

0.42

13.46

1.7

10.2

7.01

7.54

mmol/l

0.58

1504

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

328

2102

1.57

13.43

1.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

258

1562

1.66

13.33

1.3

1.6

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

322

2060

1.57

13.29

1.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

159

836

1.91

13.27

1.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

435

6246

0.69

13.02

1.8

2.0

1.24

2.13

ug/l

1.89

388

5613

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

4209

37857

1.15

12.86

1.3

1.67

1.70

u/ml

0.04

869

10426

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

841

6461

1.32

12.66

2.5

2.4

4.16

4.25

g/l

1.69

757

5935

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

212

3525

0.60

12.58

2.2

2.4

97.29

108.22

ug/min

0.15

119

2119

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

354

5249

0.67

12.56

1.5

1.8

—

32.21

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

841

6468

1.32

12.56

2.5

2.4

7.06

7.39

g/l

7.25

755

5935

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

142

734

1.94

12.50

1.1

5.63

7.52

u/ml

0.47

123

(1761868) Lipid panel - Serum or Plasma

5650

61279

0.88

12.46

2.7

3.2

—

(1002224) Polysomnography panel

989

7783

1.29

12.44

1.1

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

159

856

1.87

12.38

1.2

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

170

935

1.83

12.37

1.5

6.09

8.17

ug/l

2.58

163

848

(3021960) Folate [Moles/volume] in Serum or Plasma

4924

44853

1.14

12.36

1.6

1.7

21.66

20.29

nmol/l

9.06

3949

38251

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

836

6449

1.31

12.22

2.5

2.4

3.56

3.70

g/l

1.87

750

5921

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

321

2.44

12.18

1.1

—

(3045414) Leukocytes [Presence] in Urine

1853

15677

1.20

12.04

2.2

2.1

0.00

0.02

estimate

6.85

210

3272

(3026493) Urate [Moles/volume] in Serum or Plasma

4651

42274

1.14

12.00

2.5

2.7

328.31

337.56

umol/l

9.60

4036

37477

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1907

0.47

11.98

1.4

1.5

59.50

59.65

ug/l

0.01

1907

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

162

890

1.83

11.85

1.1

1.22

1.10

u/l

0.76

362

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

191

1103

1.74

11.81

1.1

25.64

19.14

u/ml

0.84

447

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1721

14487

1.21

11.78

2.1

2.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

400

2754

1.46

11.73

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

404

2792

1.46

11.62

1.5

1.17

1.15

ratio

0.21

236

1692

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

404

2800

1.45

11.46

1.5

1.17

1.21

ratio

0.45

239

1712

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

404

2800

1.45

11.46

1.5

0.98

0.95

ratio

0.81

236

1701

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

577

7730

0.74

11.40

2.9

4.1

51.11

48.17

2.26

570

7623

(3038026) Centromere Ab [Units/volume] in Serum

212

1274

1.67

11.35

1.3

1.2

35.81

54.27

u/ml

0.70

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

1242

0.37

11.18

1.3

1.5

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

141

2519

0.56

11.02

1.4

1.6

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

122

632

1.94

10.75

2.0

2.1

40.84

40.22

g/l

0.47

122

632

(3012544) pH of Venous blood

1340

16056

0.82

10.60

2.9

4.1

7.38

1.31

624

9177

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

717

5526

1.31

10.59

2.5

2.4

9.98

10.11

g/l

0.37

623

4944

(3000475) Leukocytes [#/volume] in Synovial fluid

549

4074

1.36

10.51

1.6

10448.05

13524.65

e6/l

1.39

386

2870

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2420

27530

0.86

10.46

2.8

3.6

0.83

0.82

mmol/l

10.34

2240

26007

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

162

2.91

10.45

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

353

5043

0.69

10.34

2.6

3.3

0.36

0.35

iu/ml

0.11

177

2786

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1028

8314

1.25

10.33

1.1

0.78

7.74

u/ml

—

100

(3051387) C reactive protein [Mass/volume] in Capillary blood

194

3135

0.61

10.32

3.4

3.5

30.50

26.28

mg/l

0.49

2159

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

145

2521

0.57

10.31

1.4

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

12576

121697

1.13

10.27

4.5

4.6

14.62

14.75

pmol/l

8.27

11393

112596

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1322

15801

0.82

10.18

2.8

4.1

5.80

5.82

kpa

0.23

1295

15426

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

109

2044

0.53

10.10

1.5

—

(3033099) Centromere Ab [Titer] in Serum

415

2.13

10.06

1.1

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1523

17914

0.84

9.86

1.7

1.9

—

(3004775) Volume in Urine collected for unspecified duration

1169

0.39

9.82

2.6

2.3

626.08

662.94

0.32

822

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

685

5303

1.30

9.82

1.1

0.60

0.62

ratio

0.33

713

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

413

2963

1.40

9.75

1.6

1.5

67.62

60.28

ug/l

0.87

335

2442

(3013139) Helicobacter pylori Ag [Presence] in Stool

1373

11515

1.21

9.74

1.3

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

12307

126898

0.89

9.74

17.4

19.8

13.42

13.61

66.63

12186

125328

(3002032) Base excess in Venous blood by calculation

1292

15397

0.83

9.63

2.8

4.1

1.60

1.83

mmol/l

1.82

1173

13570

(3004119) Hemoglobin [Mass/volume] in Venous blood

772

9716

0.78

9.60

2.1

3.5

134.07

129.30

g/l

8.98

753

9440

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1027

8380

1.24

9.54

1.1

—

(3008898) HLA-B27 [Presence]

707

5520

1.29

9.51

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

197

1219

1.62

9.49

1.1

8.52

8.57

iu/ml

0.01

303

(4027681) Cerebrospinal fluid IgG ratio and IgG index

164

968

1.70

9.48

1.2

0.59

0.68

ratio

0.52

107

550

(36304419) Bacteria [Presence] in Urine

4605

42332

1.12

9.41

3.2

0.35

274.41

estimate

0.86

164

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

4767

51579

0.89

9.29

2.5

2.7

62.56

64.99

u/l

0.37

4310

47870

(3005719) IgG [Mass/volume] in Serum or Plasma

1517

12897

1.19

9.29

2.8

2.9

10.40

10.50

g/l

0.44

1424

11950

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

924

0.35

9.07

1.4

1.5

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

895

7241

1.25

8.99

2.0

42.30

39.57

u/l

3.62

789

6472

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

963

0.36

8.97

1.4

1.5

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

962

0.36

8.95

21.2

20.3

1314.94

2419.08

nmol/l

0.57

925

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

160

2.75

8.92

1.1

1.0

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

253

1683

1.51

8.92

1.6

1.7

—

(3000494) Fungus identified in Specimen by Culture

2273

20032

1.16

8.90

1.4

1.5

—

(3044889) 12 lead EKG panel

10458

108591

0.90

8.90

3.7

4.0

0.18

3394.59

1.18

225

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

155

2.78

8.87

1.1

1.0

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

150

2.80

8.81

1.0

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

3059

27540

1.13

8.75

1.9

—

(40762814) Titanium [Mass/volume] in Blood

232

2.42

8.74

2.7

2.5

2.97

3.78

ug/l

1.17

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

274

1864

1.48

8.67

1.5

1.8

11226.67

1453.15

titre

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

162

978

1.66

8.65

1.1

4.59

7.88

nmol/l

0.59

183

(3041354) Potassium [Moles/volume] in Venous blood

1612

0.52

8.47

1.9

2.3

4.02

4.03

mmol/l

0.08

1596

(3035285) Chloride [Moles/volume] in Venous blood

1611

0.52

8.46

1.9

2.3

106.07

105.47

mmol/l

0.59

1595

(3019150) Specific gravity of Urine by Refractometry

3367

36998

0.89

8.45

3.6

4.1

1.02

1.14

kg/l

1.09

2066

24539

(3018095) Leukocytes [#/volume] in Urine

6276

58923

1.10

8.37

4.0

52.13

94.90

e6/l

10.95

3935

41367

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1108

9239

1.21

8.36

1.6

1.7

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

369

5035

0.73

8.30

2.8

3.5

1.28

1.52

mg/l

11.76

343

4611

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

356

2567

1.40

8.23

1.2

0.70

1.07

0.93

100

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1023

0.41

8.19

1.3

1.4

—

(3000850) Epithelial cells [#/volume] in Urine

3234

35563

0.89

8.18

2.5

2.8

4.75

5.76

e6/l

3.51

2867

32438

(3025018) Bordetella pertussis Ab [Titer] in Serum

181

1144

1.59

8.07

1.3

1.2

—

(3023183) Ammonium ion [Moles/volume] in Plasma

240

3505

0.68

8.02

3.1

2.8

31.77

34.03

umol/l

0.82

214

3175

(3049717) Cytology report of Urine Cyto stain

693

5522

1.27

7.98

2.7

2.6

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

1580

0.53

7.97

1.9

2.3

1.20

mmol/l

0.31

1564

(3003434) Protein [Mass/volume] in Pleural fluid

124

2084

0.59

7.86

1.4

1.5

33.32

33.61

g/l

0.10

113

1904

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

513

0.19

7.78

1.1

3.5

11.92

10.42

kpa

—

513

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

512

0.19

7.75

1.1

3.5

4.65

4.96

kpa

—

512

(4146454) Self-monitoring of blood glucose

244

1662

1.47

7.73

2.8

2.7

—

(3006576) Bicarbonate [Moles/volume] in Blood

507

0.20

7.65

5.8

6.5

26.17

25.06

mmol/l

—

463

(3005033) Fetal Nuchal fold Thickness US

318

2281

1.40

7.62

1.5

1.28

1.25

0.42

230

1640

(3047352) Trisomy 18 risk [Likelihood] in Fetus

323

2324

1.40

7.60

1.5

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

659

5257

1.26

7.53

1.8

1.18

1.20

g/l

0.67

625

5030

(3043238) Trisomy 21 risk [Likelihood] in Fetus

330

2387

1.39

7.53

1.6

—

(3004451) EKG impression Narrative

886

0.39

7.52

1.4

1.3

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

194

2.43

7.45

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

864

0.39

7.38

1.5

2.1

7.36

8.08

mmol/l

0.78

864

(3001122) Ferritin [Mass/volume] in Serum or Plasma

7892

75190

1.09

7.35

3.1

3.2

108.64

124.81

ug/l

8.79

7306

70463

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1222

0.49

7.33

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

220

3206

0.68

7.31

1.3

1.4

—

(4015189) Microbial culture of sputum

385

1.98

7.29

1.6

2.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

180

2724

0.66

7.25

1.6

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

609

4837

1.27

7.24

1.3

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

585

4624

1.27

7.23

1.9

44.76

41.70

nmol/l

2.40

570

4502

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

639

5105

1.26

7.23

1.9

1.8

0.23

0.24

g/l

0.95

601

4865

(3042631) Mycobacterium sp identified in Specimen

128

2085

0.61

7.19

2.8

2.7

—

(37208534) Antinuclear antibody arbitrary concentration in serum

543

1.81

7.17

1.1

—

(3023419) Bacteria identified in Sputum by Culture

133

2143

0.62

7.14

2.5

2.6

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

147

2308

0.63

7.05

4.8

6.5

10.75

11.85

mg/l

2.56

136

2140

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

306

4184

0.73

7.04

1.6

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

689

5575

1.25

6.99

3.1

4.0

24.94

24.87

mmol/l

0.31

638

5160

(3015736) pH of Urine

7097

67408

1.09

6.95

3.2

3.5

6.20

6.22

0.48

3431

37664

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

299

2160

1.39

6.92

1.1

3.69

3.58

eliau/ml

0.03

115

1017

(40761535) Cells panel - Urine sediment

1334

11505

1.17

6.91

3.2

3.5

—

0.83

—

(3017569) Oxygen content in Arterial blood

866

0.41

6.90

2.1

2.4

16.18

15.93

0.18

866

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

252

3543

0.71

6.88

2.8

3.7

413.68

859.13

u/ml

0.63

224

3225

(3029075) Extractable nuclear Ab panel - Serum

164

1057

1.56

6.80

1.1

—

0.33

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

129

2068

0.62

6.80

1.3

7.19

7.33

mmol/l

0.17

109

1833

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

227

3242

0.70

6.79

1.6

2.0

0.87

0.85

nmol/l

0.12

189

2756

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

226

1559

1.46

6.77

1.7

1.8

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1517

13245

1.16

6.71

1.7

1.8

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

891

7447

1.21

6.62

1.4

—

(3025130) Human papilloma virus identified in Specimen

337

2505

1.35

6.55

1.7

1.8

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

324

4338

0.74

6.52

1.7

1.6

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1133

13191

0.85

6.47

2.0

2.5

0.38

0.40

e6/l

0.20

1048

12598

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

455

1.83

6.34

2.6

3.3

1.94

1.92

ratio

0.03

413

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

163

1071

1.53

6.24

2.3

2.7

0.70

0.69

e9/l

0.07

158

1016

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

228

3201

0.71

6.22

1.3

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

136

2107

0.64

6.20

1.4

1.5

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

434

3374

1.29

6.18

2.0

1.8

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

642

5230

1.24

6.17

1.2

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

280

3786

0.74

6.05

1.3

1.4

—

(3002523) Influenza virus A Ag [Presence] in Specimen

372

2847

1.31

5.97

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

149

2245

0.66

5.96

4.7

5.5

364.85

364.79

umol/l

0.00

117

1970

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

241

1727

1.40

5.92

1.4

1.5

—

(3001893) Eosinophils/Leukocytes in Pleural fluid

422

0.24

5.85

1.3

1.4

1.50

2.47

—

365

(3003329) Lymphocytes/Leukocytes in Synovial fluid

1472

0.59

5.79

1.5

1.6

35.28

31.53

0.47

865

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

748

0.43

5.79

4.0

4.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

370

2845

1.31

5.75

1.1

—

(4094501) Cardiovascular stress test using bicycle ergometer

565

4577

1.24

5.74

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

153

1012

1.52

5.72

1.3

157.75

176.20

pmol/l

0.82

153

1012

(3036071) Salmonella sp Ab [Titer] in Serum

478

1.76

5.72

1.1

—

(21494755) Public health laboratory ask at order entry panel

1616

14355

1.14

5.60

1.4

—

(40768797) Stomach Pathology biopsy report

2520

22997

1.11

5.54

1.3

1.2

—

(3035880) pH of Pleural fluid

774

0.45

5.51

1.1

1.3

7.43

7.41

0.50

540

(3022948) Iron [Moles/volume] in Serum or Plasma

2538

27734

0.90

5.50

2.3

2.7

14.31

13.19

umol/l

11.83

2395

25897

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

564

4594

1.24

5.47

2.1

12.34

11.43

mg/l

1.37

523

4312

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2345

25723

0.90

5.46

1.8

1.9

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

8329

80112

1.08

5.45

5.7

7.5

1.22

1.21

mmol/l

17.91

7385

69360

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

709

5929

1.20

5.30

1.3

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

143

2.38

5.28

1.0

1.1

0.08

0.03

u/ml

0.52

143

(3036048) Francisella tularensis Ab [Titer] in Serum

366

1.83

5.25

1.1

1.2

—

836.36

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

1423

0.61

5.11

1.3

268.14

412.48

u/l

2.94

1360

(3030467) Casts [#/volume] in Urine by Automated count

4724

44539

1.08

5.11

3.3

0.29

0.40

e6/l

3.93

3150

32537

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

188

1329

1.42

5.06

1.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

3394

31576

1.09

5.01

2.8

3.1

2.44

2.45

mmol/l

6.54

2995

28467

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

1448

12867

1.14

5.01

1.5

—

(3000919) Neutrophils/Leukocytes in Pleural fluid

380

0.26

4.97

1.3

1.4

34.58

21.60

—

344

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

2103

19116

1.11

4.96

2.6

2.8

7.00

8.46

umol/l

3.09

1866

16677

(3020650) Glucose [Presence] in Urine

559

0.39

4.93

2.8

1.6

0.14

0.04

estimate

0.32

559

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

321

2479

1.30

4.90

1.2

3.15

3.84

u/ml

0.68

157

1150

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

161

2.24

4.89

1.3

1.2

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.34

4.87

1.0

1.1

0.04

u/ml

0.12

(3041806) Other cells [#/volume] in Blood by Manual count

391

1.77

4.83

1.5

0.57

0.51

e9/l

1.41

391

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

145

986

1.47

4.82

1.4

1.5

5.57

6.02

u/l

0.56

123

854

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

425

3408

1.25

4.80

1.1

2.26

1.87

u/ml

0.31

234

1820

(3007853) Bacteria identified in Skin by Aerobe culture

1721

19071

0.89

4.80

1.6

1.8

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

1373

0.62

4.77

1.8

1.4

1.00

1.25

promille

0.88

1066

(3045424) Erythrocytes [Presence] in Urine

933

8068

1.17

4.75

2.2

0.00

0.24

estimate

1.08

162

2588

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

650

5455

1.20

4.72

1.7

1.9

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

404

5025

0.80

4.70

2.3

2.2

5522.21

5105.28

u/l

0.11

151

1914

(3023199) Leukocytes [#/volume] in Pleural fluid

124

1839

0.67

4.69

1.5

2907.70

3154.01

e6/l

0.07

1286

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1724

19056

0.89

4.60

1.7

1.8

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

286

2196

1.31

4.59

1.8

2.1

3.62

8.08

titre

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

816

7004

1.17

4.58

1.5

1.6

11.86

15.22

iu/ml

0.33

187

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

263

3430

0.76

4.53

1.4

1.5

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

326

1.81

4.52

1.1

29.78

31.91

iu/ml

0.12

326

(3024354) Oxygen [Partial pressure] in Venous blood

1158

13099

0.88

4.52

2.3

3.5

4.60

4.56

kpa

0.28

1134

12757

(3024891) Influenza virus A+B Ag [Presence] in Specimen

491

4029

1.23

4.51

1.1

—

(3010375) cycloSPORINE [Mass/volume] in Blood

727

0.49

4.47

24.9

29.7

115.81

114.99

ug/l

0.03

589

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

5168

49122

1.07

4.40

2.1

2.2

153.74

202.26

u/l

9.35

4890

46453

(3005011) Chlamydia sp Ab [Titer] in Serum

209

2.01

4.39

1.7

1.6

—

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

106

2.46

4.36

1.5

1.4

11.70

35.71

3.24

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

203

2.02

4.35

1.0

1.1

0.29

0.18

u/ml

0.23

131

(3034988) Calcium [Moles/volume] in Capillary blood

276

0.29

4.34

1.4

2.0

1.14

1.18

mmol/l

—

261

(3042936) Bacteria identified in Isolate by Culture

2097

22872

0.91

4.34

1.7

2.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

487

4011

1.22

4.33

1.2

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

636

5374

1.19

4.32

1.5

0.32

8.81

iu/ml

1.22

118

1018

(3042733) HLA Ab [Presence] in Serum

554

0.43

4.32

3.9

4.9

—

(3051101) Glucose [Moles/volume] in Cord blood

238

0.25

4.31

2.7

6.1

7.17

8.50

mmol/l

—

238

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2382

25806

0.91

4.28

2.3

2.6

2.37

2.34

g/l

1.27

2208

23913

(40757373) Influenza virus identified in Isolate

285

0.32

4.19

1.1

1.7

—

(3043410) Blood group antigens tested for on Red Blood Cells

401

0.35

4.14

1.5

1.8

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

1313

0.64

4.14

1.6

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

848

0.55

4.10

1.3

5.64

5.80

mmol/l

0.67

798

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

230

1.92

4.03

1.6

2.5

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1046

9239

1.14

4.01

2.2

2.0

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

642

0.50

3.95

1.8

2.1

833.40

2972.56

e6/l

0.80

429

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

517

4328

1.20

3.93

1.4

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

363

2934

1.24

3.90

1.1

3.64

4.64

u/ml

0.98

198

1529

(3013727) Leukocytes other/Leukocytes in Blood

474

0.42

3.88

3.1

3.7

43.13

52.81

1.03

460

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

335

1.73

3.88

1.2

339.28

323.87

pmol/l

0.06

247

(3022475) Manganese [Moles/volume] in Blood

100

2.40

3.88

1.0

1.3

0.17

0.16

umol/l

0.17

100

(3045683) HLA typing for celiac disease panel - Blood or Tissue

135

950

1.42

3.84

1.0

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

428

3529

1.22

3.82

1.9

204.48

199.29

pmol/l

0.51

402

3346

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

600

1.54

3.82

2.0

1.9

—

(3052592) Norovirus Ag [Presence] in Stool

256

0.31

3.81

1.0

1.3

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

552

0.47

3.79

1.7

1.9

2681.62

13383.72

e6/l

1.61

278

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

272

0.33

3.79

1.7

2.0

1.17

1.19

mmol/l

—

261

(3045788) Cell count panel - Pleural fluid

101

1489

0.68

3.79

1.5

—

(3003181) Sodium [Moles/volume] in Urine

229

2963

0.77

3.78

1.3

1.4

59.31

62.67

mmol/l

0.67

179

2366

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2204

23800

0.92

3.68

2.3

2.7

24.06

22.63

5.65

2081

22151

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

107

727

1.47

3.67

1.6

1.7

29.94

29.30

umol/l

0.28

101

686

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

448

1.61

3.67

1.6

1.7

0.34

0.39

ug/l

0.59

335

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

262

2055

1.28

3.66

1.1

0.74

0.49

u/ml

0.27

681

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

117

1667

0.70

3.66

1.0

1.2

—

33.88

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

113

1619

0.70

3.65

1.5

35452.78

56434.07

e6/l

0.94

893

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

359

0.36

3.61

1.1

—

39.21

u/ml

—

(3003129) Base excess in Capillary blood by calculation

245

1911

1.29

3.59

2.0

2.3

0.65

0.57

mmol/l

0.15

239

1846

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

666

1.49

3.58

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

232

0.30

3.57

9.9

11.1

5.09

5.30

mmol/l

—

232

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

424

0.42

3.48

5.2

7.5

6.11

5.96

kpa

0.37

381

(3027923) C peptide [Moles/volume] in Serum or Plasma

943

0.61

3.47

1.8

1.5

1.25

1.24

nmol/l

0.01

722

(3004446) Plasmodium sp identified in Blood by Light microscopy

145

2.07

3.46

2.1

2.7

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

146

1983

0.73

3.44

1.0

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

153

1123

1.37

3.44

2.5

2.7

229.48

236.45

e6/l

0.19

132

960

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

103

705

1.46

3.43

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

103

705

1.46

3.43

1.4

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

377

0.40

3.40

3.1

2.3

6.60

102.05

ug/l

0.68

377

(3023430) Cat dander IgE Ab [Units/volume] in Serum

285

2282

1.25

3.39

1.1

3.89

4.84

u/ml

0.49

124

1008

(21494434) Karyotype in Bone marrow

180

1358

1.33

3.39

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

210

1619

1.30

3.39

1.2

1.3

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

160

1187

1.35

3.37

1.4

10.55

12.56

umol/l

5.58

150

1119

(3024316) Viscosity of Plasma

2.47

3.28

1.1

1.8

1.51

1.58

mpas

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

861

7618

1.14

3.28

2.1

1.9

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

299

2418

1.24

3.27

1.1

3.47

4.02

u/ml

0.23

136

1188

(40768806) Pleura Pathology biopsy report

111

1561

0.71

3.27

1.5

1.6

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

193

1479

1.31

3.27

1.4

42092.03

130219.57

e6/l

2.79

128

986

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1454

15918

0.91

3.26

2.4

2.3

378.68

376.69

nmol/l

0.14

1344

14798

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

197

2543

0.77

3.26

1.1

81.15

5229.46

iu/ml

0.66

532

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

223

2829

0.79

3.21

1.8

1.7

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

1389

0.70

3.18

1.2

1.3

9.78

8.74

mmol/l

1.25

1310

(3013005) Retinol [Moles/volume] in Serum or Plasma

107

750

1.43

3.18

1.6

1.8

2.03

1.97

umol/l

0.39

692

(3018418) pH of Serum or Plasma

4650

48607

0.94

3.18

3.7

4.4

7.40

2.15

2974

34741

(3035947) Staphylolysin Ab [Units/volume] in Serum

108

762

1.42

3.11

1.1

3.83

3.77

iu/ml

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

682

5966

1.15

3.09

1.9

2.0

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

5776

55606

1.06

3.08

3.3

3.6

2.37

2.36

mmol/l

8.47

5002

50793

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

301

0.37

3.05

6.7

6.6

10.64

10.49

0.08

301

(44790049) Parainfluenza type 3 nucleic acid detection

163

2135

0.76

3.04

1.4

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

163

2135

0.76

3.04

1.4

1.5

—

(44790048) Parainfluenza type 2 nucleic acid detection

163

2135

0.76

3.04

1.4

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

163

2135

0.76

3.04

1.4

1.5

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

343

2839

1.21

3.03

1.1

0.61

1.04

u/ml

2.05

156

1251

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

1163

0.68

3.03

1.8

1.9

1.07

1.81

u/field

1.23

642

(3008116) Ketones [Moles/volume] in Urine by Test strip

361

1.61

3.02

1.2

1.5

0.27

0.31

mmol/l

0.10

(3010726) Horse dander IgE Ab [Units/volume] in Serum

333

2752

1.21

2.99

1.1

1.40

1.63

u/ml

0.22

167

1396

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

177

0.28

2.95

1.6

1.2

5.24

5.98

mmol/l

—

177

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

547

1.48

2.95

1.6

2.0

9.34

9.12

mg/l

0.12

457

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

175

1347

1.30

2.92

1.1

295.81

291.11

mg/l

0.32

157

1220

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

125

1687

0.74

2.89

1.4

1.3

1.38

1.49

nmol/l

0.41

104

1520

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

299

3627

0.82

2.89

4.0

6.0

482.39

1464.63

iu/ml

1.19

539

(3039162) Centromere protein B Ab [Units/volume] in Serum

269

2187

1.23

2.86

1.1

1.3

76.97

62.15

u/ml

—

139

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

472

5490

0.86

2.83

2.5

2.7

—

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

401

0.47

2.82

1.1

1.3

53.09

40.46

0.60

269

(3001186) Copper [Moles/volume] in Serum or Plasma

439

1.53

2.82

1.4

1.3

17.37

16.74

umol/l

0.50

380

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

795

0.63

2.80

1.3

1.9

162.85

129.42

umol/l

0.23

396

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

144

1088

1.33

2.76

2.3

2.5

456.53

527.00

e6/l

1.34

120

876

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

197

1553

1.27

2.75

1.3

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1259

11508

1.10

2.74

1.2

160.65

137.95

u/ml

1.02

429

4440

(3002621) Streptococcal DNAse B [Units/volume] in Serum

145

1.93

2.74

1.0

1.1

169.80

354.84

u/ml

—

(3044007) Cell count panel - Peritoneal fluid

540

0.55

2.73

1.7

1.9

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

184

1440

1.28

2.73

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

388

1.55

2.70

1.2

1.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

380

0.47

2.69

5.2

7.3

5.03

5.45

kpa

0.81

380

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

120

886

1.36

2.69

1.1

1569.99

1542.59

miu/ml

0.09

120

886

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1350

12394

1.10

2.69

1.4

1.5

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

213

1701

1.26

2.68

1.6

1.8

307.96

359.18

mu/l

2.74

174

1341

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

592

1.44

2.68

2.1

2.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

592

1.44

2.68

2.1

2.2

—

(3024471) HLA-A [Type]

522

0.55

2.65

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.33

2.64

1.0

1.4

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

948

10481

0.90

2.62

3.1

3.8

5.09

5.15

kpa

1.81

893

10048

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

222

1787

1.25

2.61

1.1

98.61

96.82

0.51

204

1683

(3024666) Lithium [Moles/volume] in Serum or Plasma

924

0.67

2.59

11.2

13.7

0.60

0.63

mmol/l

0.53

842

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

544

4751

1.15

2.59

2.3

2.5

179.39

193.14

3.67

512

4516

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

599

1.42

2.53

2.1

2.2

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

436

0.53

2.52

1.3

1.2

4.15

11.78

pmol/l

—

161

(3052851) Hemolysis interference index of Serum or Plasma

503

4379

1.15

2.51

2.7

3.1

3.22

2.27

index

0.46

235

2221

(3013826) Glucose [Moles/volume] in Serum or Plasma

9013

92151

0.95

2.50

4.2

5.2

6.40

6.67

mmol/l

43.12

8549

87497

(3026470) Cobalt [Mass/volume] in Blood

119

891

1.34

2.47

2.4

2.2

5.46

3.59

ug/l

0.93

109

829

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

225

1.69

2.45

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

568

4999

1.14

2.44

1.2

1.3

—

(3017354) Segmented neutrophils/Leukocytes in Blood

215

1742

1.24

2.42

3.8

3.5

54.73

57.26

1.00

190

1514

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

224

2738

0.82

2.41

1.5

1.3

33.56

30.73

u/l

0.16

193

2366

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

291

2432

1.20

2.41

1.1

—

(3000492) Spirometry study

1729

16129

1.08

2.39

1.5

—

20.46

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

408

1.50

2.39

1.4

1.7

49.58

137.45

au/ml

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

111

827

1.34

2.39

1.3

4.18

4.43

umol/l

0.43

735

(3005322) IgE [Units/volume] in Serum or Plasma

1202

11044

1.10

2.38

1.3

185.73

245.34

u/ml

1.40

1131

10265

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

6.25

2.37

1.0

1.3

—

(3001556) Androgen free Index in Serum or Plasma

118

1.95

2.34

1.6

1.2

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

832

0.67

2.34

1.5

7.71

8.04

mmol/l

0.69

794

(3050129) First trimester maternal screen panel - Serum or Plasma

402

3463

1.16

2.34

1.5

1.4

—

(3025577) Chromium [Mass/volume] in Blood

115

865

1.33

2.33

2.3

2.2

3.33

2.37

ug/l

0.94

720

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

559

1.42

2.33

1.3

1.2

108.48

110.40

0.28

499

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

168

1330

1.27

2.33

1.1

1.2

350.00

143.57

titre

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

280

2341

1.20

2.32

1.1

122.07

117.74

1.41

248

2123

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

168

1332

1.26

2.30

1.1

1.2

183.33

202.01

titre

0.11

224

(3024932) HLA-DR beta [Type]

511

0.59

2.29

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

172

0.35

2.25

2.0

2.5

0.50

0.61

u/field

—

172

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

113

1.95

2.24

1.0

1.2

0.49

0.67

iu/ml

0.41

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

286

0.45

2.23

2.5

2.8

11.56

41.46

mg/l

—

(4195642) Thrombophilia screening test

279

2342

1.19

2.23

1.2

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

332

2830

1.18

2.22

1.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.86

2.20

1.0

1.1

2.50

3.14

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

303

1.55

2.20

1.0

1.1

1.07

1.80

u/ml

0.27

258

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

299

2529

1.19

2.20

1.2

3.06

3.38

u/ml

0.16

108

928

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

516

1.42

2.19

1.1

1.0

5.73

10.91

u/ml

2.35

325

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

675

0.65

2.17

3.1

3.5

1.60

1.33

0.58

675

(40768793) Breast Pathology biopsy report

481

4224

1.14

2.17

1.3

—

(3020876) Protein [Mass/time] in 24 hour Urine

158

1979

0.80

2.17

1.9

2.5

1.03

1.21

g/24h

0.28

1179

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

257

1.60

2.16

1.1

1.65

7.91

u/ml

1.08

171

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

291

2460

1.19

2.16

1.4

28.98

31.33

u/l

0.52

232

2002

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1258

0.75

2.16

1.3

1.2

—

(3002719) Hemoglobin [Mass/volume] in Urine

3.69

2.15

1.0

1.2

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

502

1.42

2.13

1.0

1.1

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

802

8830

0.90

2.11

3.0

3.6

1.40

1.79

mmol/l

3.16

605

6582

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

512

1.41

2.10

1.2

1.1

90.67

88.63

0.17

235

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

131

1022

1.28

2.08

1.2

1.3

74.29

61.23

titre

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

239

2855

0.83

2.07

2.5

2.8

529.62

3016.39

u/ml

1.03

150

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

2.56

2.07

1.0

1.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

598

1.37

2.07

1.4

1.2

0.30

g/l

0.08

480

(3048879) Bone marrow aspiration report

391

1.46

2.02

2.1

2.0

—

2.00

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

159

0.38

2.01

1.2

—

0.45

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

2.22

2.00

1.1

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

476

1.41

1.98

1.1

1.3

148.93

129.20

nmol/l

0.55

349

(3027456) Digoxin [Moles/volume] in Serum or Plasma

227

2711

0.84

1.98

3.6

3.2

0.74

0.81

nmol/l

2.58

175

2178

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

344

1.48

1.98

1.2

1.1

103.11

78.92

—

106

(4038314) Semen analysis, post vasectomy

2.14

1.98

1.1

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

196

2372

0.82

1.97

1.3

295.06

372.75

pmol/l

0.85

178

2025

(3002331) Protein [Mass/volume] in Peritoneal fluid

389

0.56

1.97

1.1

1.4

29.76

25.14

g/l

0.71

298

(21494815) CD4 cells/Lymphocytes in Specimen

170

1379

1.24

1.96

1.9

2.3

42.11

39.16

1.81

165

1351

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

117

908

1.29

1.96

1.1

—

(3009343) pH of Capillary blood

935

10174

0.91

1.95

3.1

3.8

7.42

4.10

730

8497

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

163

2006

0.81

1.94

1.0

1.1

—

(3022725) Serotonin [Moles/volume] in Serum

2.19

1.94

1.5

1.3

436.29

953.68

nmol/l

1.26

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.19

1.94

1.0

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

598

1.36

1.92

1.1

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

143

1141

1.26

1.92

1.3

1.2

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

145

1161

1.25

1.89

1.1

—

0.57

—

(3016244) Insulin [Units/volume] in Serum or Plasma

122

957

1.28

1.89

3.6

3.3

22.13

26.55

mu/l

0.89

113

908

(3014111) Lactate [Moles/volume] in Serum or Plasma

1531

14360

1.07

1.88

6.1

8.1

1.27

1.33

mmol/l

0.93

1490

14106

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

141

1127

1.25

1.87

1.3

1.2

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

5807

56470

1.04

1.87

3.3

3.5

1.23

2.07

e6/l

—

(3036670) Protein [Mass/volume] in Synovial fluid

482

1.39

1.87

1.3

38.21

39.78

g/l

0.36

253

(3036312) Salmon IgE Ab [Units/volume] in Serum

1.98

1.84

1.1

1.0

2.06

0.27

u/ml

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

132

1050

1.26

1.83

1.2

1.3

20.00

540.96

titre

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

342

1.46

1.83

1.2

62.29

72.15

—

100

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

501

1.38

1.83

1.1

1.2

1158.82

973.08

titre

0.73

104

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

647

0.68

1.82

3.5

1.7

8639.38

353.74

pmol/l

—

108

(3005570) Glucose [Moles/volume] in Urine

123

1548

0.79

1.82

1.8

2.0

—

0.86

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

194

1611

1.21

1.81

3.8

3.7

—

(4268621) Lupus anticoagulant assay

215

1803

1.19

1.81

2.2

2.3

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

741

6757

1.10

1.80

1.3

0.41

1.07

u/ml

2.28

555

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

101

1.88

1.80

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

235

0.47

1.80

1.0

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

377

0.58

1.79

1.1

1.2

—

(40768800) Prostate Pathology biopsy report

321

2785

1.16

1.79

1.3

1.2

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

105

815

1.29

1.78

1.1

1.2

—

(4024509) Urine culture

805

7375

1.10

1.78

1.9

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

102

1.86

1.75

1.0

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

412

0.61

1.75

1.1

1.3

2.27

272.19

ug/l

2.54

223

(3026389) Candida sp identified in Specimen by Organism specific culture

215

2546

0.84

1.75

1.3

1.4

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

138

0.36

1.73

1.6

1.3

21.88

21.13

mmol/l

—

106

(3014599) Egg white IgE Ab [Units/volume] in Serum

119

943

1.26

1.73

1.0

1.1

2.25

6.33

u/ml

0.45

233

(3024869) Neuronal Ab [Presence] in Serum

306

1.47

1.71

1.1

—

(3008295) Osmolality of Serum or Plasma

144

1767

0.81

1.71

1.8

1.4

278.79

278.63

mosm/kgh2o

0.03

1347

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

1.70

0.0

2.2

—

4.41

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

1.70

0.0

8.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1084

11639

0.93

1.67

1.6

1.7

—

(3013336) Amino acids [Identifier] in Serum or Plasma

2.58

1.65

1.0

2.7

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

772

1.28

1.65

2.5

1.9

139.90

152.13

0.88

727

(3037692) Legionella sp identified in Specimen by Organism specific culture

573

0.68

1.64

1.5

1.4

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

354

0.59

1.63

1.2

1.3

1.20

1.18

mmol/l

0.63

354

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

504

1.35

1.62

1.5

1.1

89.23

90.41

0.07

237

(3032352) Blasts [#/volume] in Cerebral spinal fluid

174

1.61

1.60

2.1

2.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

128

1.72

1.59

1.2

1.1

—

(3023383) Lactate [Moles/volume] in Pleural fluid

437

0.64

1.58

1.2

1.3

2.95

3.47

mmol/l

0.70

401

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

2.33

1.58

1.0

1.1

0.17

0.22

g/l

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

835

0.74

1.58

1.5

1.7

3.97

7.27

nmol/l

0.41

686

(3036489) Thrombin time

670

6128

1.10

1.57

1.8

2.1

20.47

21.07

2.05

592

5396

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

144

1.67

1.57

1.0

1.1

2.07

1.66

iu/ml

0.56

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2494

23887

1.05

1.56

1.6

1.7

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.88

1.54

1.1

1.0

—

(40768446) Kidney Pathology biopsy report

682

0.72

1.54

1.3

1.7

—

(3006270) Folate [Moles/volume] in Blood

139

1139

1.22

1.53

1.2

1.1

382.65

366.89

nmol/l

0.40

130

980

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

192

1.56

1.53

1.1

1.5

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

108

861

1.26

1.53

1.0

0.30

0.98

u/ml

1.00

212

(37021550) Renin [Units/volume] in Plasma --upright

306

1.44

1.53

1.3

93.41

70.82

mu/l

0.19

229

(3017817) Protein [Mass] in Urine collected for unspecified duration

110

1368

0.80

1.52

1.9

2.6

764.61

1078.25

1.77

110

1355

(3021367) Citalopram [Moles/volume] in Serum or Plasma

0.00

1.52

0.0

1.3

—

132.75

—

(3044927) Protein electrophoresis panel - Urine

176

1478

1.19

1.51

1.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

217

1.52

1.50

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

304

2667

1.14

1.50

1.2

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

257

0.54

1.49

1.7

1.6

—

(3020491) Glucose [Moles/volume] in Blood

131

1071

1.22

1.49

1.4

1.8

6.28

6.73

mmol/l

2.08

110

745

(3023511) Choriogonadotropin [Units/volume] in Urine

205

2397

0.85

1.48

1.3

—

(3011048) Pyruvate [Moles/volume] in Blood

1.81

1.46

1.6

1.2

69.53

80.89

umol/l

0.89

(3020874) Milk IgE Ab [Units/volume] in Serum

119

966

1.23

1.45

1.0

1.1

0.98

1.85

u/ml

0.57

315

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

132

1.67

1.45

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

132

1.67

1.45

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

332

2938

1.13

1.45

1.6

0.73

0.75

g/l

0.14

281

2268

(3022493) Free Hemoglobin [Mass/volume] in Plasma

673

0.73

1.44

3.0

4.8

4688.50

604.84

mg/l

0.41

484

(3029612) Listeria sp Ab [Titer] in Serum

2.73

1.43

1.2

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

2.03

1.43

1.0

1.1

4.99

0.51

u/ml

0.43

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

2.03

1.43

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.79

1.42

1.1

1.0

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3126

30172

1.04

1.41

3.6

3.9

320.24

434.06

ng/l

1.10

2373

23001

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

118

1.70

1.40

1.1

1.2

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

465

4209

1.11

1.38

1.1

4.09

7.39

eliau/ml

1.29

522

(3014148) Varicella zoster virus Ab [Titer] in Serum

250

2182

1.15

1.36

1.2

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

786

1.25

1.35

4.1

6.2

11766.80

5407.66

u/ml

—

134

(3014891) Appearance of Pleural fluid

162

0.49

1.35

2.0

1.6

—

(3000060) B lymphocytes [#/volume] in Blood

460

1.33

1.35

2.0

2.2

0.18

0.50

e9/l

0.96

217

(3022764) Mononuclear cells/Leukocytes in Peritoneal fluid

0.00

1.34

0.0

8.6

—

51.69

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

247

0.57

1.33

1.8

1.9

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

566

1.29

1.33

1.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

165

1400

1.18

1.30

1.2

122.73

109.21

pmol/l

1.07

165

1400

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.74

1.30

1.2

1.5

346.94

303.80

umol/24h

0.52

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

918

0.78

1.28

1.2

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

226

1.46

1.28

1.1

1.0

12.35

8.00

u/ml

0.25

226

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

131

0.46

1.28

1.0

1.1

—

18.30

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

774

8314

0.93

1.27

2.1

3.2

1.14

1.26

3.50

768

8274

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

748

1.24

1.27

1.2

10.33

10.24

mm/h

0.03

748

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2324

24165

0.96

1.27

2.0

2.2

29.31

29.54

1.25

2283

23534

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

243

1.44

1.27

2.4

1.7

—

(4212803) Bone marrow aspirate examination

130

1.62

1.26

1.0

1.1

—

(3045142) Bone marrow Pathology biopsy report

211

1833

1.15

1.25

1.3

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

663

7157

0.92

1.25

1.7

1.35

1.56

g/l

8.82

558

6192

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.74

1.24

1.1

1.2

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

563

0.73

1.24

2.7

3.2

28.33

28.25

umol/l

0.01

425

(3006922) Hepatitis E virus Ab [Presence] in Serum

160

1361

1.18

1.24

1.1

—

(3017509) Phencyclidine [Presence] in Urine

160

0.50

1.23

1.6

1.4

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

100

1.70

1.23

4.7

6.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

364

1.35

1.22

1.1

1.2

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

2.63

1.21

1.2

1.0

4500.00

2913.68

titre

—

(3011436) Histone Ab [Units/volume] in Serum

348

1.35

1.20

1.1

—

21.20

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1182

12477

0.94

1.17

2.0

2.3

7.66

7.61

ug/l

0.02

1004

11083

(3018834) Bilirubin.total [Presence] in Urine by Test strip

1.70

1.17

3.6

3.8

—

0.00

estimate

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

157

1.53

1.17

1.0

0.00

0.18

u/ml

0.97

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.77

1.16

1.0

1.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

201

2300

0.87

1.15

2.9

2.7

5.00

834.38

u/ml

1.29

201

2278

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

257

1.40

1.15

1.3

1.1

—

(3020630) Protein [Mass/volume] in Serum or Plasma

1402

13350

1.05

1.15

2.6

2.7

66.87

66.43

g/l

1.60

1262

12314

(3019174) dRVVT (LA screen)

134

1.57

1.14

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

216

1.44

1.13

1.2

1.1

—

(3036603) Volume of Urine

149

1273

1.17

1.12

1.7

1.6

2044.42

1973.86

0.48

149

1240

(3002582) Erythrocytes [#/volume] in Urine

5261

51487

1.03

1.12

3.3

3.4

67.62

74.98

e6/l

0.11

3713

39246

(3003694) ABO and Rh group [Type] in Blood

4391

44986

0.97

1.12

1.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

127

1071

1.19

1.12

1.4

—

(4198724) Urine methamphetamine measurement

654

0.76

1.12

1.6

2.6

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

221

0.59

1.11

1.2

2.2

0.51

1.11

mmol/l

—

150

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

200

1749

1.15

1.11

1.1

0.89

1.98

iu/ml

—

(40768795) Lymph node Pathology biopsy report

149

1737

0.86

1.11

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

120

1423

0.84

1.10

2.9

3.0

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

555

5997

0.92

1.10

3.5

3.7

411.09

1738.73

u/ml

1.77

480

5179

(3032057) Clostridioides difficile [Presence] in Stool

302

1.36

1.10

1.8

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

521

1.27

1.09

1.1

1.3

3.90

26.38

5.75

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

100

1204

0.83

1.09

2.0

2.1

—

(3011985) Renin [Units/volume] in Plasma

226

2554

0.88

1.09

1.5

65.41

63.13

mu/l

0.06

200

2292

(3024561) Albumin [Mass/volume] in Serum or Plasma

7053

71709

0.97

1.08

4.2

5.2

36.93

35.83

g/l

65.01

6594

67501

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

984

0.81

1.08

1.2

1.1

16.25

23.68

u/l

2.07

877

(3017143) Hepatitis C virus Ab [Presence] in Serum

1918

18439

1.05

1.07

1.5

1.6

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

138

1178

1.17

1.07

1.1

1.2

83.02

81.78

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

278

1.37

1.07

1.0

1.1

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

992

0.82

1.06

1.2

1.1

76.38

82.73

u/l

0.52

881

(4034850) Laboratory test

517

4779

1.08

1.05

8.0

9.9

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

279

1.36

1.05

1.0

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

279

1.36

1.05

1.0

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

235

2640

0.89

1.04

1.5

1.7

—

(3010838) Calcium [Moles/time] in 24 hour Urine

352

3199

1.10

1.04

1.9

5.28

5.10

mmol/24h

0.47

307

2862

(3000330) Specific gravity of Urine by Test strip

813

7645

1.07

1.04

2.9

3.3

1.02

ratio

2.11

702

6895

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

154

1.49

1.03

1.0

0.01

0.06

u/ml

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

824

1.20

1.03

2.0

1.9

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

824

1.20

1.03

2.0

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

824

1.20

1.03

2.0

1.9

—

(3009677) Dengue virus Ab [Presence] in Serum

1.83

1.02

1.2

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

1371

13100

1.05

1.01

2.8

2.7

72.42

67.42

ml/min/173m2

5.92

525

5477

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

826

1.20

1.01

2.0

1.9

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.88

1.00

1.2

1.1

28.09

62.57

umol/24h

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

172

1964

0.87

1.00

1.5

1.6

46.65

57.07

2.93

122

1207

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

940

0.82

0.99

1.1

1.04

1.06

ratio

1.93

778

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

484

5229

0.92

0.99

1.5

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

192

1692

1.14

0.99

2.0

2.1

5.31

8.44

umol/l

3.06

138

1236

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

2.17

0.98

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

2.17

0.98

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

2.17

0.98

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

2.17

0.98

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

2.17

0.98

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

2.17

0.98

2.0

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

2.17

0.98

1.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

157

0.57

0.98

1.1

—

(3028433) Virus identified in Specimen by Culture

503

1.25

0.98

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

172

1506

1.14

0.97

3.7

3.8

—

(3033086) Enterovirus Ab [Titer] in Serum

1.80

0.96

1.0

—

(3001218) Citrate [Mass/time] in 24 hour Urine

0.00

0.96

0.0

1.5

—

437.55

—

(3017950) Salicylates [Moles/volume] in Serum or Plasma

0.00

0.96

0.0

1.5

—

1702.00

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

109

1283

0.85

0.96

2.0

2.3

18.96

18.01

nmol/l

0.53

104

1210

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

319

2902

1.10

0.95

3.4

3.8

31.11

35.73

u/ml

0.23

309

2810

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

198

0.61

0.95

1.2

1.1

—

(3011412) CD3 cells [#/volume] in Blood

177

1558

1.14

0.94

2.3

2.4

1203.32

1202.68

e6/l

0.00

155

1375

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

977

0.83

0.94

2.9

2.8

41.79

38.87

0.55

545

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

242

1.36

0.94

1.8

2.0

—

(21494890) Protein electrophoresis panel - 24 hour Urine

142

1634

0.87

0.94

2.0

2.1

—

(40758292) HTLV I+II Ab panel - Serum

312

1.31

0.92

1.3

—

(40757494) Bilirubin.total [Moles/volume] in Blood

789

0.81

0.92

1.8

2.2

42.77

37.50

umol/l

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

362

3321

1.09

0.91

1.2

1.4

9.01

25.51

u/ml

—

(3035350) Ketones [Presence] in Urine by Test strip

8361

84672

0.98

0.91

3.5

3.9

8.90

3.33

estimate

0.76

883

18051

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

554

1.23

0.90

3.3

3.6

8.62

8.63

mg/l

0.00

446

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

296

1.32

0.90

1.8

1.4

15058.33

278744.52

u/ml

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

102

1.57

0.90

1.3

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

101

0.49

0.89

2.4

2.1

0.60

ug/l

—

101

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

574

0.78

0.88

1.4

14.71

15.34

pmol/l

0.42

474

(3024928) Oxygen saturation in Venous blood

432

4003

1.08

0.87

1.9

3.5

60.93

61.99

0.45

423

3874

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

5771

58682

0.97

0.86

3.3

3.7

33.37

63.50

ng/l

2.35

3775

39822

(3020961) Endomysium IgA Ab [Titer] in Serum

824

7811

1.06

0.85

1.1

175.56

204.78

titre

0.20

219

(4133840) Spirometry

402

0.75

0.85

1.1

1.2

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

145

1.45

0.84

1.0

0.10

0.60

u/ml

—

(3019309) Folate [Moles/volume] in Red Blood Cells

2453

25245

0.97

0.84

1.6

1.7

1046.08

1163.28

nmol/l

8.41

1691

19314

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

1.94

0.84

1.0

1.1

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

110

945

1.17

0.84

2.1

2.2

100.12

97.98

0.30

102

884

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

713

0.81

0.84

1.9

2.1

24.94

136.78

ug/min

2.28

161

(3024263) Appearance of Synovial fluid

780

1.18

0.83

1.6

1.7

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

129

1.47

0.83

1.4

1.6

0.69

1.61

mg/l

1.42

(3042517) Benzodiazepines panel - Urine

178

0.62

0.82

1.2

2.5

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

786

0.83

0.81

1.1

1.3

94.08

63.80

6.67

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

608

5725

1.06

0.80

1.8

2.3

168.44

586.29

ug/l

10.19

558

5425

(3035637) Corticotropin [Mass/volume] in Plasma

201

2234

0.90

0.80

1.5

24.66

29.64

ng/l

1.65

201

2227

(3000093) Morphology [Interpretation] in Blood Narrative

168

1494

1.13

0.80

1.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

432

4637

0.93

0.79

1.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

553

5194

1.07

0.79

1.4

283.35

275.03

ug/g

0.44

304

3017

(21491868) Cryoglobulin [Mass/volume] in Serum

600

1.20

0.79

1.2

0.09

0.22

g/l

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

104

1205

0.86

0.79

1.7

1.8

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

190

1.37

0.78

1.4

1.3

—

(3004809) Band form neutrophils/Leukocytes in Blood

246

2702

0.91

0.78

3.7

3.5

1.68

1.58

0.13

223

2452

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

348

1.27

0.78

1.2

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

474

1.22

0.78

1.1

1.2

—

(3016038) Potassium [Moles/volume] in Urine

1063

0.86

0.77

1.1

1.2

40.52

34.38

mmol/l

1.28

930

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

630

5949

1.06

0.77

1.3

1.4

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

502

1.22

0.77

2.4

2.7

38.84

145.29

au/ml

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

361

3346

1.08

0.76

1.2

1.4

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

235

1.32

0.75

1.0

78.20

78.67

ug/l

0.02

185

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

197

0.66

0.75

1.2

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

262

2860

0.91

0.74

1.3

—

14.60

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

2.08

0.74

1.0

2.79

0.51

u/ml

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

544

5124

1.06

0.73

2.0

2.3

94.50

93.18

0.82

525

4934

(3025941) Bacteria identified in Stool by Culture

916

8758

1.05

0.72

1.2

1.3

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

1.55

0.71

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

443

1.22

0.71

1.3

1.5

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

645

1.18

0.71

1.7

1.4

38.60

34.21

nmol/l

0.55

573

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

489

0.80

0.70

1.1

1.6

—

173.63

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

465

4368

1.07

0.69

1.4

10.74

11.12

u/l

0.23

369

3486

(3017732) Neutrophils [#/volume] in Blood

2140

20829

1.03

0.68

3.0

3.2

4.26

4.42

e9/l

0.37

1605

18199

(3037756) Immunofixation for Serum or Plasma

305

3291

0.93

0.68

1.9

1.7

—

(3014271) Vancomycin [Susceptibility]

621

1.18

0.67

2.5

2.9

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

320

1.25

0.67

1.5

1.9

3.70

3.03

ug/l

0.15

189

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.63

0.66

1.1

1.0

—

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

1.79

0.66

1.0

0.03

0.05

u/ml

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

330

1.24

0.66

1.2

1.1

2.48

0.66

umol/24h

0.46

153

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

111

1.44

0.65

1.0

1.1

0.02

0.22

u/ml

1.83

111

(40765089) Chromosome analysis panel - Blood by G-banded

394

1.22

0.65

1.0

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

103

1.46

0.64

1.1

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

542

1.18

0.63

1.1

1.2

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

155

1.36

0.62

1.0

1.1

5.33

5.08

u/ml

0.02

122

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

101

0.59

0.62

1.7

1.2

27.00

1044.14

u/l

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

652

6838

0.95

0.61

1.7

0.28

0.31

mg/l

0.84

279

3248

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

330

3532

0.93

0.61

1.5

1.7

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

119

1060

1.12

0.60

1.2

1.3

16.23

23.28

u/l

2.19

875

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.60

0.0

1.2

—

0.53

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.60

0.0

2.7

—

(3026726) Creatinine [Moles/volume] in Specimen

140

0.64

0.60

1.3

2.6

527.22

391.75

umol/l

—

134

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.60

0.0

1.0

—

(3013676) Sertraline [Moles/volume] in Serum or Plasma

0.00

0.60

0.0

1.3

—

110.88

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

1.54

0.59

1.1

1.3

1.30

1.37

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

140

1552

0.90

0.59

1.2

1.3

—

(3045177) Copper [Moles/volume] in Urine

0.00

0.58

0.0

1.1

—

0.56

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

332

0.78

0.58

6.5

4.7

58.31

57.40

u/l

0.01

324

(3027945) Reticulocytes/Erythrocytes in Blood

1739

17861

0.97

0.57

2.3

2.6

1.66

1.79

7.74

1523

16039

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

1.71

0.57

1.0

1.1

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

123

1.38

0.57

1.4

1.6

2.03

1.84

mg/l

0.08

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

123

1.38

0.57

1.4

1.6

0.72

0.62

mg/l

0.12

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

123

1.38

0.57

1.4

1.6

4.57

3.97

mg/l

0.15

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

126

1132

1.11

0.56

1.0

769.45

739.51

ng/l

0.28

798

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.67

0.56

1.0

1.1

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

220

1.27

0.56

1.2

1.3

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1874

19219

0.97

0.56

1.6

1.8

1.37

1.45

5.87

1642

16807

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

310

1.23

0.56

1.0

1.2

—

(4035726) Immunohistochemistry procedure

1499

14569

1.03

0.56

1.4

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

107

1.40

0.55

1.0

1.1

7.53

11.13

u/l

0.72

107

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

126

1135

1.11

0.54

1.0

38.17

42.12

ng/l

0.65

817

(3013762) Body weight Measured

1.54

0.53

1.3

1.2

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

125

1129

1.11

0.52

1.0

287.18

329.42

ng/l

1.43

827

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

673

0.86

0.52

1.1

1.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.61

0.52

5.7

5.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

120

1083

1.11

0.51

1.3

75.66

88.10

u/l

1.23

103

913

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1648

16898

0.97

0.50

3.9

4.4

12.20

25.00

ug/l

1.30

1264

13731

(3017315) Amylase [Enzymatic activity/volume] in Urine

847

1.12

0.50

1.3

1.2

305.72

382.87

u/l

0.38

776

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

144

1.32

0.50

1.1

102.74

94.44

titre

0.12

144

(3023323) Follitropin [Units/volume] in Serum or Plasma

855

8250

1.04

0.50

1.4

31.11

29.83

iu/l

0.50

727

7054

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

150

1373

1.09

0.49

1.8

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

150

1373

1.09

0.49

1.8

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

150

1373

1.09

0.49

1.8

1.7

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

669

0.87

0.49

1.0

1.1

104.46

95.64

1.27

535

(3027135) IgG subclass 1 [Mass/volume] in Serum

197

1827

1.08

0.48

1.4

6.41

6.78

g/l

0.93

164

1309

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.45

0.48

1.2

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

1.45

0.48

1.0

0.02

0.07

u/ml

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1016

0.90

0.47

6.9

7.1

45.87

97.72

ug/l

0.48

655

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

190

1762

1.08

0.47

2.3

2.4

36.17

26.21

iu/ml

0.37

195

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

355

1.18

0.46

1.1

—

(3023520) Reticulocytes [#/volume] in Blood

1351

13865

0.97

0.46

2.3

2.6

66.65

70.23

e9/l

3.59

935

10212

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

117

0.68

0.45

2.4

5.8

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

108

979

1.10

0.45

1.4

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

196

1825

1.07

0.44

1.4

0.35

0.41

g/l

2.02

164

1305

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

588

0.87

0.44

2.7

0.61

mmol/l

0.14

588

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

657

1.13

0.44

2.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

340

0.82

0.43

2.2

2.3

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

266

2507

1.06

0.43

1.5

1.4

0.32

0.36

nmol/l

0.81

204

1847

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

177

1645

1.08

0.43

1.8

1.4

3.44

3.89

ug/l

0.39

153

1385

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

777

0.89

0.43

1.5

1.8

0.87

2.82

u/field

4.54

557

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

477

4978

0.96

0.42

1.3

220.16

222.18

miu/ml

0.05

235

2232

(3020717) Zinc [Moles/volume] in Serum or Plasma

108

984

1.10

0.41

1.3

1.5

30.19

23.64

umol/l

1.11

913

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

0.41

0.0

1.1

—

293.27

—

(3036005) Urine sediment comments by Light microscopy Narrative

0.00

0.41

0.0

1.1

—

(3044316) Mercury [Moles/volume] in Urine

0.00

0.41

0.0

2.5

—

8.68

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.41

0.0

1.2

—

36.42

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

1036

0.91

0.41

1.6

1.5

7.57

6.71

u/l

0.24

818

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.40

0.0

1.2

—

69.04

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.40

0.0

1.1

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

195

1826

1.07

0.40

1.4

2.84

2.91

g/l

0.27

164

1310

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

129

1191

1.08

0.38

1.4

1.5

23.00

24.16

u/ml

0.09

219

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.38

0.38

14.6

8.4

—

(3017704) Immunofixation for Urine

801

0.90

0.38

1.9

1.7

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.34

0.38

1.1

1.3

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1556

15885

0.98

0.38

2.4

2.3

0.23

0.21

g/l

12.25

1448

14877

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

136

0.74

0.37

1.7

1.4

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

4042

40891

0.98

0.37

2.2

2.4

2.59

2.78

mg/l

5.73

3322

35526

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

112

0.71

0.37

1.5

1.9

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

169

0.77

0.36

2.2

3.3

0.71

1.09

mg/l

—

120

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

311

2966

1.05

0.36

1.2

497.67

302.74

titre

0.40

232

(3020123) Porphyrins [Interpretation] in Serum or Plasma

1.31

0.35

1.0

1.1

—

(3016031) Almond IgE Ab [Units/volume] in Serum

108

1.30

0.35

1.1

1.0

0.07

0.59

u/ml

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

108

996

1.08

0.34

1.4

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

163

1529

1.07

0.34

4.7

5.4

39.04

102.17

u/ml

3.34

500

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

741

0.90

0.33

1.1

8.90

12.64

u/ml

—

(4062490) Immunoglobulin typing, IgG

190

1793

1.06

0.33

1.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

1043

10189

1.03

0.33

1.9

1.37

1.30

g/l

0.42

949

9408

(3032868) Hemoglobin electrophoresis panel in Blood

144

0.76

0.33

1.6

1.5

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

408

3926

1.04

0.33

1.4

107.14

154.50

pmol/l

1.73

399

3827

(3012898) Urea [Moles/volume] in Urine

166

0.78

0.33

1.5

231.23

168.33

mmol/l

1.35

147

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

0.68

0.33

1.0

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

413

0.87

0.32

1.1

0.90

10.34

u/ml

0.61

228

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

262

2498

1.05

0.32

1.3

0.58

2.45

nmol/l

1.30

248

2411

(1617658) Protocol used for examination of sentinel lymph nodes

138

1291

1.07

0.32

1.0

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

128

1.25

0.31

1.8

2.6

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

306

2931

1.04

0.31

1.2

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

306

2931

1.04

0.31

1.2

1.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

317

3040

1.04

0.31

1.2

1.5

146.84

151.34

au/ml

0.32

121

843

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

230

1.17

0.30

2.0

—

(40768441) Liver Pathology biopsy report

119

1274

0.93

0.30

1.5

1.4

—

(44813793) Dust mix specific IgE antibody measurement

128

1198

1.07

0.30

1.1

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

333

3203

1.04

0.29

1.2

1.3

253.82

267.56

u/ml

0.37

218

2004

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

148

1.22

0.29

1.0

1.1

0.02

1.89

u/ml

1.96

119

(3029396) Erythrocyte agglutination [Presence] in Blood

324

0.86

0.29

2.8

2.9

—

(3000991) Gas panel - Venous blood

1418

13931

1.02

0.29

7.1

9.4

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

106

0.75

0.29

1.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

487

1.11

0.29

1.0

0.34

0.70

u/ml

0.81

475

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

228

2177

1.05

0.28

1.3

0.27

0.20

nmol/l

0.35

175

1692

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

738

1.08

0.27

1.1

168.23

186.96

iu/ml

0.17

729

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

186

1.18

0.27

1.2

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

464

4786

0.97

0.27

3.5

3.3

3.38

3.53

ratio

0.04

254

2739

(3013637) Mi-2 Ab [Presence] in Serum

470

1.11

0.27

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

470

1.11

0.27

1.2

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

470

1.11

0.27

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

470

1.11

0.27

1.2

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.68

0.26

1.0

1.2

—

(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.23

0.25

1.0

1.1

8.34

8.60

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

181

0.83

0.25

1.4

1.2

64.07

68.19

ug/l

0.07

181

(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.22

0.25

1.0

1.1

23.34

20.87

—

(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis

1.22

0.25

1.0

1.1

37.61

36.33

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

129

1364

0.95

0.24

1.5

1.8

3.24

3.86

mg/l

2.07

123

1313

(3027008) Opiates [Presence] in Urine

608

5934

1.03

0.24

1.6

1.9

—

(3013466) aPTT in Blood by Coagulation assay

0.71

0.24

1.2

1.1

35.57

36.70

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

152

1.18

0.23

1.0

0.03

0.10

u/ml

0.96

101

(1001926) Buprenorphine [Presence] in Urine by Screen method

448

4606

0.97

0.23

1.8

2.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

209

2005

1.04

0.23

1.1

1.2

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1103

10848

1.02

0.22

3.2

3.5

4.53

4.46

pmol/l

1.16

956

9778

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

981

9640

1.02

0.22

8.1

10.0

24.41

24.28

mmol/l

0.71

954

9476

(3002079) Sodium [Moles/time] in 24 hour Urine

803

0.93

0.21

1.3

1.2

145.03

161.64

mmol/24h

1.35

803

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

107

1.22

0.21

1.3

0.81

1.05

ml/s/173m2

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.21

0.0

1.3

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

0.21

0.0

1.0

—

21.09

—

(3008896) Cortisol [Moles/volume] in Urine

0.00

0.21

0.0

1.0

—

196.73

—

(3044590) Delta aminolevulinate [Moles/volume] in Urine

0.00

0.21

0.0

1.0

—

17.36

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

39.11

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.21

0.0

1.2

—

(3009410) PHENobarbital [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

8.1

—

91.86

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

188

0.85

0.21

2.0

1.9

1.61

1.69

mg/l

0.08

160

(3016273) Islet cell 512 Ab [Units/volume] in Serum

103

0.78

0.21

1.0

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

239

1.13

0.21

1.9

1.8

—

(3026906) Gabapentin [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.1

—

90.80

—

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(36660577) Edoxaban [Mass/volume] in Platelet poor plasma by Chromogenic method

0.00

0.21

0.0

1.4

—

84.50

—

(3009261) Glucose [Presence] in Urine by Test strip

8560

85261

1.01

0.20

3.6

4.0

0.00

0.29

estimate

1.86

846

17106

(3042951) Complement C1q Ab [Units/volume] in Serum

1.25

0.20

1.1

—

22.15

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.20

0.0

1.0

—

(3001729) Color of Synovial fluid

115

0.78

0.20

1.6

—

(3020393) Adenovirus Ag [Presence] in Stool

155

1.16

0.19

1.1

1.3

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

365

0.90

0.19

1.3

1.4

—

(3000764) Benzodiazepines [Presence] in Urine

602

5898

1.02

0.19

1.6

2.0

—

(4281824) Cell count and differential, peritoneal fluid

189

1962

0.96

0.19

1.1

—

(3028300) Cannabinoids [Presence] in Urine

607

5951

1.02

0.19

1.6

2.0

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

705

1.06

0.18

1.5

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

125

1194

1.05

0.18

3.9

3.5

103.61

162.63

nmol/l

1.68

125

1183

(3003577) Lead [Moles/volume] in Blood

132

0.83

0.18

2.3

1.4

0.22

0.16

umol/l

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

333

3419

0.97

0.18

1.6

—

(3009871) Measles virus Ab [Titer] in Serum

682

0.94

0.17

1.7

1.6

3993.85

3318.88

titre

0.29

107

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

281

1.10

0.17

1.3

—

(3021601) Nitrite [Presence] in Urine by Test strip

8339

83682

0.99

0.17

3.5

3.9

0.00

estimate

0.06

857

17650

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

191

1846

1.04

0.17

1.2

52.98

63.04

u/l

3.50

171

1609

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

120

0.83

0.16

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

272

2795

0.97

0.16

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

608

0.94

0.16

1.4

85.29

222.27

nmol/24h

1.72

608

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

4577

45524

1.01

0.16

2.7

3.1

754.03

1178.33

ng/l

26.83

3745

39216

(40758358) Immune stain study

1.14

0.16

1.0

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

178

1841

0.97

0.16

1.3

1.2

41.40

30.93

nmol/l

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

788

1.05

0.16

1.6

2.4

—

(3010937) Rubella virus Ab [Presence] in Serum

1.20

0.16

1.1

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.78

0.15

1.0

1.3

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.14

0.15

1.0

1.5

—

(3028707) Methadone [Presence] in Urine by Screen method

260

2534

1.03

0.15

2.1

2.7

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.10

0.15

1.2

1.6

—

(21494814) CD8 cells/Lymphocytes in Specimen

644

1.06

0.14

1.8

2.1

31.44

31.19

0.05

644

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.80

0.14

1.6

1.5

1001.70

482.84

nmol/l

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

408

4159

0.98

0.14

1.3

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

325

0.92

0.13

2.1

18.13

16.53

umol/l

0.49

325

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

470

4779

0.98

0.13

1.8

2.0

4.11

12.15

iu/l

1.08

150

1986

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

1.17

0.13

1.1

26.20

23.16

u/ml

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

1.17

0.13

1.1

38.60

24.72

u/ml

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

190

0.89

0.13

1.0

1.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

293

0.92

0.12

3.8

3.1

50.52

43.76

0.98

293

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

152

1.12

0.12

1.0

0.19

0.67

u/ml

—

(3016879) Cocaine [Presence] in Urine

559

5511

1.01

0.12

1.7

2.1

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

246

2406

1.02

0.12

1.1

1.47

1.51

g/l

0.70

222

2193

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

292

0.92

0.11

7.6

6.2

7.22

8.67

0.65

292

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

133

1290

1.03

0.11

1.2

1.3

1.16

1.82

u/ml

0.78

747

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

942

9325

1.01

0.11

3.2

3.8

52.52

59.86

u/ml

0.20

913

9017

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

240

0.92

0.11

1.2

102.77

121.30

ng/l

0.14

156

(3034426) Prothrombin time (PT)

523

1.05

0.11

1.1

1.2

27.09

28.29

1.25

523

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

818

1.04

0.11

1.1

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

261

2558

1.02

0.11

1.3

0.15

0.23

nmol/l

1.35

174

(3050794) Legionella sp Ab [Presence] in Serum

157

0.89

0.11

1.0

1.1

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

157

0.89

0.11

1.9

1.7

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

408

1.05

0.09

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.15

0.09

1.0

1.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

491

4970

0.99

0.09

1.3

1.2

178.18

126.82

titre

0.26

475

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

548

1.04

0.08

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

516

5215

0.99

0.08

1.6

1.7

267.88

300.97

mu/l

2.72

475

4734

(3009015) Lactate [Moles/volume] in Synovial fluid

185

1.08

0.08

1.5

1.2

4.83

6.42

mmol/l

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.77

0.08

1.0

1.1

1.39

1.30

mom

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1258

12500

1.01

0.08

3.0

4.0

72.63

88.66

ng/l

14.90

1099

10852

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

940

9330

1.01

0.08

2.9

4.3

24.38

24.24

mmol/l

0.85

928

9228

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

1.08

0.08

2.7

10.9

98.57

104.78

g/l

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

156

1.09

0.08

1.2

1.1

2.30

1.67

umol/24h

0.39

156

(3013862) HLA-DP [Type]

1.04

0.08

1.0

—

(46235168) Fasting glucose [Moles/volume] in Blood

176

1.08

0.07

1.0

1.5

5.87

7.05

mmol/l

—

(44806071) Cardiolipin IgM antibody measurement

225

0.93

0.07

1.0

1.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.04

0.07

1.1

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

195

1918

1.02

0.07

3.4

3.6

4.60

12.36

nmol/l

1.18

185

1855

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

748

1.03

0.07

1.4

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

748

1.03

0.07

1.4

1.5

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.07

0.07

1.1

1.0

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

681

0.97

0.07

2.8

2.4

51.58

51.92

umol/l

0.03

595

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.05

0.07

1.0

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

1.03

0.07

1.1

8.12

8.23

mmol/l

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

152

0.92

0.06

5.5

2.6

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

530

5261

1.01

0.05

1.6

955.80

1005.49

mu/l

0.78

428

4378

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

110

1.09

0.05

1.0

—

(3037121) Protein [Mass/volume] in Urine

539

5355

1.01

0.04

2.8

3.4

647.96

426.28

mg/l

0.27

209

2399

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

268

1.04

0.04

1.3

1.6

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1838

18434

1.00

0.04

4.8

4.6

232.60

243.36

u/l

3.51

1711

17558

(3027944) Amphetamines [Presence] in Urine

589

5856

1.01

0.04

1.6

2.0

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

497

4939

1.01

0.04

2.1

2.6

3.51

3.59

g/l

0.62

468

4726

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

8395

84024

1.00

0.04

6.0

6.8

11.25

11.26

umol/l

0.02

7924

80222

(3018001) Oat IgE Ab [Units/volume] in Serum

111

1.08

0.04

1.0

0.18

0.27

u/ml

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

535

5379

0.99

0.04

3.5

3.4

34.24

43.86

mg/l

0.99

487

4550

(3051611) Lipemic interference index of Serum or Plasma

155

1567

0.99

0.03

2.7

3.3

25.04

13.78

index

0.53

895

(3028717) Thiamine [Mass/volume] in Blood

240

0.96

0.03

1.1

1.2

72.39

62.11

ug/l

1.09

240

(3047189) Immunofixation for 24 hour Urine

743

0.98

0.03

1.8

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

521

0.98

0.03

1.1

1.2

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

229

0.96

0.02

1.4

1.6

108.07

114.04

ug/l

0.08

196

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

351

1.03

0.02

4.5

3.2

103.94

111.16

ng/l

0.07

148

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

7407

74113

1.00

0.02

2.5

2.8

—

estimate

—

(40765096) Chromosome analysis panel by Banding

491

1.02

0.02

1.1

—

(3034770) Mitochondria Ab [Titer] in Serum

489

4906

1.00

0.02

1.3

1.2

750.00

972.29

titre

—

153

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

613

1.01

0.01

2.0

477.70

28282.24

u/ml

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

874

1.01

0.00

1.1

—

(3002619) Bacteria identified in Specimen by Culture

429

1.00

0.00

1.1

1.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

465

0.99

0.00

1.7

10.03

9.08

ug/l

0.74

465

(3039744) RNA polymerase III Ab [Units/volume] in Serum

138

1.01

0.00

1.1

1.0

—

7.13

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

138

1.01

0.00

1.4

1.2

103.57

111.81

ug/l

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

538

5384

1.00

0.00

3.5

36.77

60.40

mg/l

1.61

484

4560

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

100

1003

1.00

0.00

1.5

1.7

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

119

1.01

0.00

1.1

1.2

51.04

43.32

mg/l

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

131

0.99

0.00

2.2

1.7

39.62

45.55

umol/l

0.42

131

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

181

0.99

0.00

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

675

0.99

0.00

1.7

0.85

1.93

u/ml

2.19

179

(21494567) Legionella sp IgM Ab [Presence] in Serum

123

0.98

0.00

1.0

1.1

—

0.23

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

183

0.98

0.00

1.1

1.5

4.12

4.76

nmol/l

0.33

175

(3004541) Aldosterone [Moles/volume] in Urine

0.00

0.0

1.0

—

44.57

—

(3038702) Sodium [Moles/volume] in Capillary blood

0.00

0.0

4.0

—

137.17

—

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

0.0

1.0

—

(3007147) Virus identified in Stool by Electron microscopy

0.00

0.0

1.0

—

(36304079) Mucus [Presence] in Urine sediment

0.00

0.0

1.2

—

(3025830) Chlamydophila pneumoniae IgM Ab [Units/volume] in Serum

0.00

0.0

1.0

—

25.71

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

0.0

1.0

—

(44786798) Granulocytes/Leukocytes in Peritoneal dialysis fluid

0.00

-0.00

0.0

2.3

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.96

-0.00

1.0

1.9

2.02

3.49

nmol/l

—

(40763590) HLA-DQ beta [Type]

0.91

-0.00

1.0

—

(40760409) HLA-A [Type] by High resolution

0.90

-0.00

1.0

—

(3042628) Porphyrins [Moles/volume] in Urine

0.00

-0.00

0.0

1.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.96

-0.00

2.2

2.3

—

(40760512) CD34 cells/cells in Bone marrow

0.00

-0.00

0.0

1.3

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.1

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

-0.00

0.0

1.1

—

(3003095) Rheumatoid factor [Units/volume] in Synovial fluid

0.00

-0.00

0.0

1.0

—

(3009179) Lactate [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.0

—

1.82

—

(3022229) Phosphate [Moles/volume] in Urine

0.91

-0.00

1.4

1.9

11.63

18.36

mmol/l

—

(3038413) Eosinophils/Leukocytes in Peritoneal dialysis fluid by Manual count

0.00

-0.00

0.0

6.3

—

9.50

—

(40760410) HLA-B [Type] by High resolution

0.90

-0.00

1.0

—

(36031836) Tocilizumab [Mass/volume] in Serum

0.00

-0.00

0.0

1.4

—

19.78

—

(3020399) Glucose [Mass/volume] in Urine

0.00

-0.00

0.0

1.2

—

0.05

—

(46236302) HLA-C [Type] by High resolution typing

0.90

-0.00

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: AB1_SPIROCHE_OTHER_WIDE – Spirochaetal infections, other/unspecified, including avohilmo

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Spirochaetal infections, other/unspecified, including avohilmo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Spirochaetal infections, other/unspecified, including avohilmo (AB1_SPIROCHE_OTHER_WIDE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints